7 year of sacroiliac radiographic progression in early psoriatic arthritis (preliminary results) ; Рентгенологическое прогрессирование сакроилиита при раннем псориатическом артрите: данные 7-летнего наблюдения (предварительные результаты)

Συγγραφείς: E. Yu. Loginova, P. O. Tremaskina, E. E. Gubar, T. V. Korotaeva, A. V. Sukhinina, S. I. Glukhova, Е. Ю. Логинова, П. О. Тремаскина, Е. Е. Губарь, Т. В. Коротаева, А. В. Сухинина, С. И. Глухова

Συνεισφορές: Исследование проводилось в рамках выполнения научной темы № 1021051503111-9 «Совершенствование диагностики и фармакотерапии спондилоартритов на основании сравнительных результатов изучения прогностических (в том числе молекулярно-биологических, молекулярно-генетических, клинико-визуализационных) факторов прогрессирования заболевания и уровня качества жизни больных».

Πηγή: Rheumatology Science and Practice; Vol 62, No 1 (2024); 98-103 ; Научно-практическая ревматология; Vol 62, No 1 (2024); 98-103 ; 1995-4492 ; 1995-4484

Θεματικοί όροι: аксиальный псориатический артрит, radiographic progression of sacroiliitis, axial psoriatic arthritis, рентгенологическое прогрессирование сакроилиита

Περιγραφή αρχείου: application/pdf

Relation: https://rsp.mediar-press.net/rsp/article/view/3518/2353; Baraliakos X, Coates LC, Braun J. The involvement of the spine in psoriatic arthritis. Clin Exp Rheumatol. 2015;33(93):31-35.; Feld J, Ye JY, Chandran V, Inman RD, Haroon N, Cook R, et al. Axial disease in psoriatic arthritis: The presence and progression of unilateral grade 2 sacroiliitis in a psoriatic arthritis cohort. Semin Arthritis Rheum. 2021;51(2):464-468. doi:10.1016/j.semarthrit.2021.03.007; Насонов ЕЛ (ред.). Ревматология. Российские клинические рекомендации. М.:ГЭОТАР-Медиа;2017.; van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984;27:361-368.; Chandran V, Tolusso DC, Cook RJ, Gladman DD. Risk factors for axial inflammatory arthritis in patients with psoriatic arthritis. J Rheumatol. 2010;37(4):809-815. doi:10.3899/jrheum.091059; Корсакова ЮЛ, Логинова ЕЮ, Коротаева ТВ, Губарь EE, Глухова СИ, Василенко ЕА, и др. Бремя прогрессирования псориатического артрита. Данные общероссийского регистра. Терапевтический архив. 2022;94(5):622-627. doi:10.26442/00403660.2022.05.201506; Губарь ЕЕ, Логинова ЕЮ, Смирнов АВ, Глухова СИ, Коротаева ТВ, Насонов ЕЛ. Клинико-инструментальная характеристика аксиального поражения при раннем периферическом псориатическом артрите (данные исследования РЕМАРКА). Научно-практическая ревматология. 2018;56(1):34-40. doi:10.14412/1995-4484-2018-34-40; Li SS, Du N, He SH, Liang X, Li TF. Dactylitis is associated with more severe axial joint damage and higher disease activity in axial psoriatic arthritis. Rheumatol. 2022;49(9):1012-1019. doi:10.3899/jrheum.220098; Protopopov M, Poddubnyy D. Radiographic progression in nonradiographic axial spondyloarthritis. Expert Rev Clin Immunol. 2018;14(6):525-533. doi:10.1080/1744666X.2018.1477591; Dougados M, Sepriano A, Molto A, van Lunteren M, Ramiro S. Sacroiliac radiographic progression in recent onset axial spondyloarthritis: The 5-year data of the DESIR cohort. Ann Rheum Dis. 2017;76(11):1823-1828. doi:10.1136/annrheumdis2017-211596; Fernández-Carballido C, Tornero C, Castro-Villegas MC, Galindez E, García-Llorente JF; ESPERANZA study group. No radiographic sacroiliitis progression was observed in patients with early spondyloarthritis at 6 years: Results of the Esperanza multicentric prospective cohort. RMD Open. 2020;6(2):e001345. doi:10.1136/rmdopen-2020-001345

Διαθεσιμότητα: https://rsp.mediar-press.net/rsp/article/view/3518
https://doi.org/10.47360/1995-4484-2024-98-103

Progression of sacroiliitis in men and women according to the cohort of early axial spondyloarthritis (CORSAR) over 3 years of follow-up ; Прогрессирование сакроилиита у мужчин и женщин по данным когорты раннего аксиального спондилоартрита (КоРСАр) за 3 года наблюдения

Συγγραφείς: D. G. Timokhina, T. V. Dubinina, A. B. Demina, O. A. Krichevskaya, Sh. F. Erdes, Д. Г. Тимохина, Т. В. Дубинина, А. Б. Демина, О. A. Кричевская, Ш. Ф. Эрдес

Συνεισφορές: Исследование проводилось в рамках фундаментальной научной темы «Патогенетические особенности и персонифицированная терапия анкилозирующего спондилита и псориатического артрита», номер темы НИОКР АААА-А19-119021190147-6.

Πηγή: Rheumatology Science and Practice; Vol 59, No 6 (2021); 715-719 ; Научно-практическая ревматология; Vol 59, No 6 (2021); 715-719 ; 1995-4492 ; 1995-4484

Θεματικοί όροι: сакроилиит, ankylosing spondylitis, radiographic progression, sacroiliitis, анкилозирующий спондилит, рентгенологическое прогрессирование

Περιγραφή αρχείου: application/pdf

Relation: https://rsp.mediar-press.net/rsp/article/view/3106/2150; Rudwaleit M, van der Heijde D, Landew6 R, Listing J, Akkoc N, Brandt J, et al. The development of assessment of SpondyloArthritis International Society classification criteria for axial spondyloarthritis (part II): Validation and final selection. Ann Rheum Dis. 2009;68(6):777-783. doi:10.1136/ard.2009.108233; Румянцева ДГ, Дубинина ТВ, Демина АБ, Смирнов АВ, Эрдес Ш. Сравнительный анализ основных клинических проявлений у мужчин и женщин с ранним аксиальным спондилоартритом. Научно-практическая ревматология. 2019;57(4):440-444. doi:10.14412/1995-4484-2019-440-444; Tournadre A, Pereira B, Lhoste A, Dubost JJ, Ristori JM, Claudepierre P, et al. Differences between women and men with recent-onset axial spondyloarthritis: results from a prospective multicenter French cohort. Arthritis Care Res (Hoboken). 2013;65(9):1482-1489. doi:10.1002/acr.22001; Ward MM, Hendrey MR, Malley JD, Learch TJ, Davis JC Jr, Reveille JD, et al. Clinical and immunogenetic prognostic factors for radiographic severity in ankylosing spondylitis. Arthritis Rheum. 2009;61(7):859-866. doi:10.1002/art.24585; Deminger A, Klingberg E, Geijer M, Gothlin J, Hedberg M, Rehnberg E, et al. A five-year prospective study of spinal radiographic progression and its predictors in men and women with ankylosing spondylitis. Arthritis Res Ther. 2018;20(1):162. doi:10.1186/s13075-018-1665-1; Deodhar A, Strand V, Kay J, Braun J. The term ‘non-radiographic axial spondyloarthritis' is much more important to classify than to diagnose patients with axial spondyloarthritis. Ann Rheum Dis. 2016;75:791-794. doi:10.1136/annrheumdis-2015-208852; Baraliakos X, Listing J, von der Recke A, Braun J. The natural course of radiographic progression in ankylosing spondylitis: Differences between genders and appearance of characteristic radiographic features. Curr Rheumatol Rep. 2011;13(5):383-387. doi:10.1007/s11926-011-0192-8; Wanders AJ, Landew6 RB, Spoorenberg A, Dougados M, van der Linden S, Mielants H, et al. What is the most appropriate radiologic scoring method for ankylosing spondylitis? A comparison of the available methods based on the Outcome Measures in Rheumatology Clinical Trials filter. Arthritis Rheum. 2004;50(8):2622-2632. doi:10.1002/art.20446; Эрдес ШФ, Румянцева ДГ, Смирнов АВ. Оценка прогрессирования аксиального спондилоартрита на ранних стадиях болезни в реальной клинической практике: возможности использования суммарного счета рентгенологического сакроилиита. Научно-практическая ревматология. 2018;56(4):461-465. doi:10.14412/1995-4484-2018-461-465; Rios Rodriguez V, Hermann KG, WeiB A, Listing J, Haibel H, Althoff C, et al. Progression of structural damage in the sacroiliac joints in patients with early axial spondyloarthritis during longterm anti-tumor necrosis factor treatment: Six-year results of continuous treatment with etanercept. Arthritis Rheumatol. 2019;71(5):722-728. doi:10.1002/art.40786; Dougados M, Sepriano A, Molto A, van Lunteren M, Ramiro S, de Hooge M, et al. Sacroiliac radiographic progression in recent onset axial spondyloarthritis: The 5-year data of the DESIR cohort. Ann Rheum Dis. 2017;76(11):1823-1828. doi:10.1136/annrheumdis-2017-211596; Ramiro S, van der Heijde D, van Tubergen A, Stolwijk C, Dougados M, van den Bosch F, et al. Higher disease activity leads to more structural damage in the spine in ankylosing spondylitis: 12-year longitudinal data from the OASIS cohort. Ann Rheum Dis. 2014;73(8):1455-1461. doi:10.1136/annrheumdis-2014-205178; Ramiro S, Landew6 R, van Tubergen A, Boonen A, Stolwijk C, Dougados M, et al. Lifestyle factors may modify the effect of disease activity on radiographic progression in patients with ankylosing spondylitis: A longitudinal analysis. RMD Open. 2015;1(1):e000153. doi:10.1136/rmdopen-2015-000153

Διαθεσιμότητα: https://rsp.mediar-press.net/rsp/article/view/3106
https://doi.org/10.47360/1995-4484-2021-715-719

IMPACT OF THE FREQUENCY OF USING NONSTEROIDAL ANTI-INFLAMMATORY DRUGS ON THE RADIOGRAPHIC PROGRESSION OF SACROILIITIS IN PATIENTS WITH EARLY AXIAL SPONDYLOARTHRITIS ; Влияние частоты приема нестероидных противовоспалительных препаратов на рентгенологическое прогрессирование сакроилиита у пациентов с ранним аксиальным спондилоартритом

Συγγραφείς: D. G. Rumyantseva, T. V. Dubinina, Sh. F. Erdes, Д. Г. Румянцева, Т. В. Дубинина, Ш. Ф. Эрдес

Πηγή: Rheumatology Science and Practice; Vol 56, No 3 (2018); 346-350 ; Научно-практическая ревматология; Vol 56, No 3 (2018); 346-350 ; 1995-4492 ; 1995-4484 ; 10.14412/rsp20183

Θεματικοί όροι: рентгенологическое прогрессирование, axial spondyloarthrititis, ankylosing spondylitis, non-radiographic axial spondyloarthrititis, sacroiliitis, radiographic progression, аксиальный спондилоартрит, анкилозирующий спондилит, нерентгенологический аксиальный спондилоартрит, сакроилиит

Περιγραφή αρχείου: application/pdf

Relation: https://rsp.mediar-press.net/rsp/article/view/2570/1717; Rudwaleit M, van der Heijde D, Landewe R, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis. 2009;68(6):777-83. doi:10.1136/ard.2009.108233; Sieper J, Poddubnyy D. Axial spondyloarthritis. Lancet. 2017;390(10089):73-84. doi:10.1016/S0140-6736(16)31591-4; Rudwaleit M, Khan MA, Sieper J. The challenge of diagnosis and classification in early ankylosing spondylitis. Do we need new criteria? Arthritis Rheum. 2005;52(4):1000-8. doi:10.1002/art.20990; Appel H, Sipper J. Spondyloarthritis at the crossroads of imaging, pathology, and structural damage in the era of biologics. Curr Rheumatol Rep. 2008;10(5):356-63. doi:10.1007/s11926-008- 0058-x; Molto A, Paternotte S, van der Heijde D, et al. Evaluation of the validity of the different arms of the ASAS set of criteria for axial spondyloarthritis and description of the different imaging abnormalities suggestive of spondyloarthritis: data from the DESIR cohort. Ann Rheum Dis. 2015;74(4):746-51. doi:10.1136/annrheumdis-2013-204262; Rudwaleit M, Haibel H, Baraliakos X, et al. The early disease stage in axial spondylarthritis: results from the German Spondyloarthritis Inception Cohort. Arthritis Rheum. 2009;60(3):717-27. doi:10.1002/art.24483; Kiltz U, Baraliakos X, Karakostas P, et al. Do patients with nonradiographic axial spondylarthritis differ from patients with ankylosing spondylitis? Arthr Care Res. 2012;64(9):1415-22. doi:10.1002/acr.21688; Ciurea A, Scherer A, Exer P, et al. Tumor necrosis factor α inhibition in radiographic and nonradiographic axial spondyloarthritis: results from a large observational cohort. Arthritis Rheum. 2013;65(12):3096-106. doi:10.1002/art.38140; Эрдес ШФ, Дубинина ТВ, Румянцева ОА и др. Эволюция аксиального спондилоартрита за 12 месяцев наблюдения когорты КоРСАр. Научно-практическая ревматология. 2016;54(1S):55-9 [Erdes ShF, Dubinina TV, Rumyantseva OA, et al. The evolution of axial spondyloarthritis during 12-month follow-up study of a CORSAR cohort. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2016;54(1S):55-9 (In Russ.)]. doi:10.14412/1995-4484-2016-1S55-59; Landewe R, Dougados M, Mielants H, et al. Physical function in AS is independently determined by both disease activity and radiographic damage of the spine. Ann Rheum Dis. 2009;68(6):863-7. doi:10.1136/ard.2008.091793; Callhoff J, Sieper J, Weiss A, et al. Efficacy of TNFα blockers in patients with AS and non-radiographic axial spondyloarthritis: a meta-analysis. Ann Rheum Dis. 2015;74(6):1241-8. doi:10.1136/annrheumdis-2014-205322; Румянцева ДГ, Дубинина ТВ, Демина АБ и др. Анкилозирующий спондилит и нерентгенологический аксиальный спондилоартрит: две стадии одной болезни? Терапевтический архив. 2017;89(5):33-7 [Rumyantseva DG, Dubinina TV, Demina AB, et al. Ankylosing spondylitis and non-radiographic axial spondyloarthritis: Two stages of disease? Terapevticheskiy Arkhiv. 2017;89(5):33-7 (In Russ.)]. doi:10.17116/terarkh201789533-37; Lukas C, Landewe R, Sieper J, et al; Assessment of SpondyloArthritis International Society. Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis. Ann Rheum Dis. 2009;68(1):18-24. doi:10.1136/ard.2008.094870; Poddubnyy D, Haibel H, Listing J, et al. Baseline radiographic damage, elevated acute-phase reactant levels, and cigarette smoking status predict spinal radiographic progression in early axial spondylarthritis. Arthritis Rheum. 2012;64:1388-98. doi:10.1002/art.33465; Poddubnyy D, Protopopov M, Haibel H, et al. High disease activity according to the Ankylosing Spondylitis Disease Activity Score is associated with accelerated radiographic spinal progression in patients with early axial spondyloarthritis: results from the GErman SPondyloarthritis Inception Cohort. Ann Rheum Dis. 2016;75(12):2114-8. doi:10.1136/annrheumdis-2016-209209; Ramiro S, Stolwijk C, van Tubergen A, et al. Evolution of radiographic damage in ankylosing spondylitis: a 12 year prospective follow-up of the OASIS study. Ann Rheum Dis. 2015;74:52-9. doi:10.1136/annrheumdis-2013-204055; Kroon F, Burg L, Ramiro S, et al. Non-steroidal anti-inflammatory drugs in axial spondyloarthritis: a Cochrane review. J Rheumatol. 2016;43(3):607-17. doi:10.3899/jrheum.150721; Poddubnyy D, Rudwaleit M, Haibel H, et al. Effect of nonsteroidal anti-inflammatory drugs on radiographic spinal progression in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort. Ann Rheum Dis. 2012;71:1616-22. doi:10.1136/annrheumdis-2011-201252; Kroon F, Landewe R, Dougados M, van der Heijde D. Continuous NSAID use reverts the effects of inflammation on radiographic progression in patients with ankylosing spondylitis. Ann Rheum Dis. 2012;71:1623-9. doi:10.1136/annrheumdis-2012- 201370; Wanders A, van der Heijde D, Landewe R, et al. Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial. Arthritis Rheum. 2005;52(6):1756-65. doi:10.1002/art.21054; Sieper J, Rudwaleit M, Baraliakos X, et al. The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis. 2009;68(2):1-44. doi:10.1136/ard.2008.104018; Marzo-Ortega H, McGonagle D, O’Connor P, Emery P. Efficacy of etanercept in the treatment of the entheseal pathology in resistant spondylarthropathy: a clinical and magnetic resonance imaging study. Arthritis Rheum. 2001;44(9):2112-7. doi:10.1002/1529- 0131(200109)44:93.0.CO;2-H; Linden S, Valkenburg H, Cats A. Evaluation of Diagnostic Criteria for Ankylosing Spondylitis. Arthritis Rheum. 1984;27(4):361-8. doi:10.1002/art.1780270401; Dougados M, Simon P, Braun J, et al. ASAS recommendations for collecting, analysing and reporting NSAID intake in clinical trials/epidemiological studies in axial spondyloarthritis. Ann Rheum Dis. 2011;70:249-51. doi:10.1136/ard.2010.133488; Van der Heijde D, Ramiro S, Landewe R, et al. 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Ann Rheum Dis. 2017;76(6):978-91. doi:10.1136/annrheumdis-2016-210770; Гайдукова ИЗ, Ребров АП, Лапшина СА и др. Применение нестероидных противовоспалительных препаратов и генноинженерных биологических препаратов для лечения аксиальных спондилоартритов. Рекомендации Экспертной группы по изучению спондилоартритов при Общероссийской общественной организации «Ассоциация ревматологов России». Научно-практическая ревматология. 2017;55(5):474-84 [Gaidukova IZ, Rebrov AP, Lapshina SA, et al. Use of nonsteroidal anti-inflammatory drugs and biological agents for the treatment of axial spondyloarthritides. Recommendations of the Spondyloarthritis Study Group of Experts, All-Russian Public Organization «The Association of Rheumatology of Russia». Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2017;55(5):474-84 (In Russ.)]. doi:10.14412/1995- 4484-2017-474-484; Smolen JS, Schö ls M, Braun J, et al. Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force. Ann Rheum Dis. 2018;77:3-17. doi:10.1136/annrheumdis-2017-211734; Braun J, Kiltz U, Sarholz M, et al. Monitoring ankylosing spondylitis: clinically useful markers and prediction of clinical outcomes. Exp Rev Clin Immunol. 2015;11(8):935-46. doi:10.1586/1744666X.2015.1052795; Sieper J, Klopsch T, Richter M, et al. Comparison of two different dosages of celecoxib with diclofenac for the treatment of active ankylosing spondylitis: results of a 12-week randomised, doubleblind, controlled study. Ann Rheum Dis. 2008;67:323-9. doi:10.1136/ard.2007.075309; Zhang X, Schwarz EM, Young DA, et al. Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair. J Clin Invest. 2002;109(11):1405-15. doi:10.1172/JCI15681; Vuolteenaho K, Moilanen T, Moilanen E. Non-steroidal anti-infl ammatory drugs, cyclooxygenase-2 and the bone healing process. Basic Clin Pharmacol Toxicol. 2008;102:10-4. doi:10.1111/j.1742- 7843.2007.00149.x

Διαθεσιμότητα: https://rsp.mediar-press.net/rsp/article/view/2570
https://doi.org/10.14412/1995-4484-2018-346-350

ACHIEVEMENT OF MINIMAL DISEASE ACTIVITY AND PROGRESSION OF RADIOGRAPHIC CHANGES IN EARLY PSORIATIC ARTHRITIS ONE YEAR AFTER INITIATION OF TREATMENT IN «TREAT TO TARGET» STRATEGY (PRELIMINARY RESULTS OF THE REMARKA STUDY) ; Достижение минимальной активности болезни и динамика рентгенологических изменений при раннем псориатическом артрите через год после начала лечения в рамках стратегии «Лечение до достижения цели» (предварительные результаты исследования РЕМАРКА)

Συγγραφείς: E. Yu. Loginova, T. V. Korotaeva, A. V. Smirnov, A. D. Koltakova, E. L. Nasonov, Е. Ю. Логинова, Т. В. Коротаева, А. В. Смирнов, А. Д. Koлтакова, Е. Л. Насонов

Πηγή: Rheumatology Science and Practice; Vol 55, No 6 (2017); 610-615 ; Научно-практическая ревматология; Vol 55, No 6 (2017); 610-615 ; 1995-4492 ; 1995-4484 ; 10.14412/rsp20176

Θεματικοί όροι: минимальная активность болезни, treat to target strategy, radiographic progression, minimal disease activity, стратегия Т2Т, рентгенологическое прогрессирование

Περιγραφή αρχείου: application/pdf

Relation: https://rsp.mediar-press.net/rsp/article/view/2463/1633; Коротаева ТВ. Псориатический артрит. В кн.: Насонов ЕЛ, редактор. Российские клинические рекомендации. Ревматология. Москва: ГЭОТАР-Медиа; 2017. 464 с. [Korotaeva TV. Psoriatic arthritis. In: Nasonov EL, editor. Rossiiskie klinicheskie rekomendatsii. Revmatologiya [Russian clinical guidelines. Rheumatology]. Moscow: GEOTAR-Media; 2017. 464 p.].; Haque N, Lories RJ, de Vlam K. Orthopaedic interventions in patients with psoriatic arthritis: a descriptive report from the SPAR cohort. Rheumatic Musculoskeletal Dis. 2016;2:e000293.; Kane D, Stafford L, Bresnihan B, et al. A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience. Rheumatology (Oxford). 2003;42(12):1460-8. doi:10.1093/rheumatology/keg384; Gladman DD, Thavaneswaran A, Chandran V, et al. Do patients with psoriatic arthritis who present early fare better than those presenting later in the disease? Ann Rheum Dis. 2011;70(12):2152-4. doi:10.1136/ard.2011.150938; Theander E, Husmark T, Alenius GM, et al. Early psoriatic arthritis: short symptom duration, male gender and preserved physical functioning at presentation predict favorable outcome at 5-year follow-up. Results from the Swedish Early Psoriatic Arthritis Register (SwePsA). Ann Rheum Dis. 2013;73(2):407-13.; Haroon M, Gallagher P, Fitzgerald O. Diagnostic delay of more than 6 months contributes to poor radiographic and functional outcome in psoriatic arthritis. Ann Rheum Dis. 2014; published online Feb 13. doi:10.1136/annrheumdis-2013-204858; Kavanaugh A, van der Heijde D, Beutler A, et al. Radiographic progression of patients with psoriatic arthritis who achieve minimal disease activity in response to golimumab therapy: results through 5 years of a randomized, placebo-controlled study. Arthritis Care Res. 2016;68:267-74. doi:10.1002/acr.22576; Coates LC, Fransen J, Helliwell PS. Defining minimal disease activity in psoriatic arthritis: a proposed objective target for treatment. Ann Rheum Dis. 2010;69(1):48-53. doi:10.1136/ard.2008.102053; Coates LC, Helliwell PS. Validation of minimal disease activity criteria for psoriatic arthritis using interventional trial data. Arthritis Care Res. 2010;62:965-9. doi:10.1002/acr.20155; Coates LC, Helliwell PS. Comment on: Efficacy and safety of anti-TNF therapies in psoriatic arthritis: an observational study from the British Sosiety for Rheumatology Biologics Register. Rheumatology. 2010;49:1793-4. doi:10.1093/rheumatology/keq138; Coates LC, Navarro-Coy N, Brown SR, et al. The TICOPA protocol (Tight Control in Psoriatic Arthritis: a randomized controlled trial to compare intensive management versus standard care in early psoriatic arthritis. BMC Musculoskel Disor. 2013;14:101. doi: 10/1186/1471-2474-14-101; Coates LC, Moverley AR, McParland L, et al. Effect of tight control inflammation in early psoriatic arthritis (TICOPA): a UK multicenter, open-label, randomized controlled trial. Lancet. 2015;386:2489-98. doi:10.1016/S0140-6736(15)00347-5; Van der Heijde D. How to read radiographs according to the Sharp/Van der Heijde method. J Rheumatol. 2000;27:261-4.; Коротаева ТВ, Логинова ЕЮ, Каратеев ДЕ и др. Стратегия «лечения до достижения цели» при раннем ПсА (предварительные результаты исследования РЕМАРКА). Научно-практическая ревматология. 2014;52(4):376-80 [Korotaeva TV, Loginova EYu, Karateev DE, et al. Treat-to-target strategy for early psoriatic arthritis (preliminary results of the REMARCА study). Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2014;52(4):376-80 (In Russ.)]. doi:10.14412/1995-4484-2014-376-380; Harrison BJ, Silman AJ, Barrett EM, et al. Presence of psoriasis does not influence the presentation or short-term outcome of patients with early inflammatory polyarthritis. J Rheumatol. 1997;24(9):1744-9.; Lindqvist U, Alenius G-M, Husmark T, et al. The Swedish early psoriatic arthritis register – 2-year followup: a comparison with early rheumatoid arthritis. J Rheumatol. 2008;35(4):668-73.; Faustini F, Simon D, Oliveira I, et al. Subclinical joint inflammation in patients with psoriasis without concomitant psoriatic arthritis: a cross-sectional and longitudinal analysis. Ann Rheum Dis. 2016;0:1-7. doi:10.1136/annrheumdis-2015-208821; Punzi L, Pianon M, Rossini P, et al. Clinical and laboratory manifestations of elderly onset psoriatic arthritis: a comparison with younger onset disease. Ann Rheum Dis. 1999;58(4):226-9.; Красненко СО, Логинова ЕЮ, Коротаева ТВ и др. Сравнительная характеристика данных магнитно-резонансной томографии, рентгенографического и клинического исследования кистей и стоп у больных с ранним псориатическим артритом. Научно-практическая ревматология. 2013;51(2):149-53 [Krasnenko SO, Loginova EY, Korotaeva TV, Smirnov AV. Comparative characterization of the data of magnetic resonance imaging, X-ray and clinical studies of the hand and foot joints in patients with early psoriatic arthritis. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2013;51(2):149-53 (In Russ.)]. doi:10.14412/1995-4484-2013-642; Geijer M, Lindqvist U, Husmark T, et al. The Swedish early psoriatic arthritis register 5-year followup: substantial radiographic progression mainly in men with disease activity and development of dactyli-tis. J Rheumatol. 2015;42:2110-7. doi:10.3899/jrheum.150165

Διαθεσιμότητα: https://rsp.mediar-press.net/rsp/article/view/2463
https://doi.org/10.14412/1995-4484-2017-610-615

JOINT ULTRASONOGRAPHY IN RHEUMATOID ARTHRITIS: PATHOGENETIC RATIONALE, POSSIBLE USE IN DIAGNOSIS, THERAPY EFFICIENCY EVALUATION, AND OUTCOME PREDICTION ; Ультразвуковое исследование суставов при ревматоидном артрите: патогенетическая обоснованность, возможности использования в диагностике, оценке эффективности терапии и прогнозировании исходов

Συγγραφείς: O. G. Alekseeva, О. Г. Алексеева

Πηγή: Rheumatology Science and Practice; Vol 56, No 1 (2018); 82-92 ; Научно-практическая ревматология; Vol 56, No 1 (2018); 82-92 ; 1995-4492 ; 1995-4484 ; 10.14412/rsp20181

Θεματικοί όροι: рентгенологическое прогрессирование, power Doppler, grayscale, radiographic progression, энергетический допплер, «серая» шкала

Περιγραφή αρχείου: application/pdf

Relation: https://rsp.mediar-press.net/rsp/article/view/2504/1662; Wain DL. Sensitivity, specificity and responsiveness of magnetic resonance imaging and ultrasound in rheumatoid arthritis diagnosis, Bioscience Horizons. Int J Stud Res. 2014 Jan;7. doi:10.1093/biohorizons/hzu005; Sudol-Szopinska I, Jans L, Teh J. Rheumatoid arthritis: what do MRI and ultrasound show. J Ultrasonogr. 2017;17(68):5-16. doi:10.15557/JoU.2017.0001; Jacobson JA. Fundamentals of Musculoskeletal ultrasound. In: Fundamentals of Radiology Series. Elsevier Health Sciences; 2007. ISNB 1416035931, 9781416035930-345.; Babcock DS, Patriquin H, LaFortune M, Dauzat M. Power Doppler sonography: basic principles and clinical applications in children. Pediatr Radiol. 1996;26(2):109-15. doi:10.1007/BF01372087; Wakefield RJ, Balint PV, Szkudlarek M, et al. Musculoskeletal ultrasound including definitions for ultrasonographic pathology. J Rheumatol. 2005;32(12):2485-7.; McInnes IB, Schett G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol. 2007;7:429-42. doi:10.1038/nri2094; Koch AE. Review: angiogenesis: implications for rheumatoid arthritis. Arthritis Rheum. 1998;41:951-62. doi:10.1002/15290131(199806)41:63.0.CO;2-D; Folkman J. Angiogenesis and angiogenesis inhibition: an overview. EXS. 1997;79:1-8. doi:10.1007/978-3-0348-9006-9_1; Folkman J, Shing Y. Angiogenesis. J Biol Chem. 1992;267(16):1093-4.; Strunk J, Bundke E, Lange U. Anti-TNF-alpha antibody Infliximab and glucocorticoids reduce serum vascular endothelial growth factor levels in patients with rheumatoid arthritis: a pilot study. Rheumatol Int. 2006;26(3):252-6. doi:10.1007/s00296-0050619-5 [PubMed: 15999273].; Shu Q, Amin MA, Ruth JH, et al. Suppression of endothelial cell activity by inhibition of TNFalpha. Arthritis Res Ther. 2012;14(2):R88. doi:10.1186/ar3812 [PubMed: 22534470].; Taylor PC. VEGF and imaging of vessels in rheumatoid arthritis. Arthritis Res. 2002;4(Suppl 3):S99-S107. doi:10.1186/ar582; Dayer J-M, Choy E. Therapeutic targets in rheumatoid arthritis: the interleukin-6 receptor. Rheumatology. 2010;49:15-24. doi:10.1093/rheumatology/kep329; Alivernini S, Tolusso B, Petricca L, et al. Synovial features of patients with rheumatoid arthritis and psoriatic arthritis in clinical and ultrasound remission differ under anti-TNF therapy: a clue to interpret different chances of relapse after clinical remission? Ann Rheum Dis. 2017;76:1228-36. doi:10.1136/annrheumdis-2016210424; Ramirez J, Celis R, Usategui A, et al. Immunopathologic characterization of ultrasound-defined synovitis in rheumatoid arthritis patients in clinical remission. Arthritis Res Ther. 2016;18:74. doi:10.1186/s13075-016-0970-9; Baillet A, Gossec L, Paternotte S, et al. Evaluation of serum IL-6 level as a surrogate marker of synovial inflammation and as a factor of structural progression in early rheumatoid arthritis: results from a French National Multicenter Cohort. Arthritis Res Ther. 2015; 67:905-12. doi:10.1002/acr.22513; Bugatti S, Msanzo A, Benaglio F, et al. Serum levels of CXCL13 are associated with ultrasonographic synovitis and predict power Doopler persistence in early rheumatoid arthritis treated with nonbiological disease-modifying anti-rheumatic drugs. Arthritis Res Ther. 2012;14:R43. doi:10.1186/ar3742; Fazaa A, Ben Abdelghani K, Abdeladhim M, et al. The level of interleukin-17 in serum is linked to synovial hypervascularisation in rheumatoid arthritis. Joint Bone Spine. 2014;81(6):550-1. doi:10.1016/j.jbspin.2014.05.008; Ramirez J, Ruiz-Esquide V, Pomes I, et al. Patients with rheumatoid arthritis in clinical remission and ultrasound-defined active synovitis exhibit higher disease activity and increased serum levels of angiogenic biomarkers. Arthritis Res Ther. 2014;16:R5. doi:10.1186/ar4431; Hernandez Diaz C, Robles-San Roman M, Vargas A, et al. SAT0180 Subclinical Inflammation in Rheumatoid Arthritis (RA) in Clinical Remission, Lack of Association between Cytokines Level and Ultrasound-Defined Synovitis. Ann Rheum Dis. 2014;73:655. doi:10.1136/annrheumdis-2014-eular.4855; Kawashiri SY, Suzuki T, Nakashima Y, et al. Ultrasonographic examination of rheumatoid arthritis patients who are free of physical synovitis: power Doppler subclinical synovitis is associated with bone erosion. Rheumatology (Oxford). 2014 Mar;53(3):562-9. doi:10.1093/rheumatology/ket405. Epub 2013 Dec 5.; Kelly S, Bombardier M, Humby F, et al. Angiogenic gene expression and vascular density are reflect in ultrasonograhic features of synovitis in early rheumatoid arthritis: an odservational study. Arthritis Res Ther. 2015;17:58. doi:10.1186/s13075-015-0567-8; Feldmann M, Brennan FM, Maini RN. Rheumatoid arthritis. Cell. 1996;85:307-10. doi:10.1016/S0092-8674(00)81109-5 20; Feldmann M, Brennan FM, Maini RN. Role of cytokines in rheumatoid arthritis. Ann Rev Immunol. 1996;14:397-440. doi:10.1146/annurev.immunol.14.1.397; Scheel AK, Hermann K-GA, Kahler E, et al. A novel ultrasonographic synovitis scoring system suitable for analyzing finger joint inflammation in rheumatoid arthritis. Arthritis Rheum. 2005;52:733-43. doi:10.1002/art.20939; Filippucci Е, Iagnocco А, Salaffi F, et al. Power Doppler sonography monitoring of synovial perfusion at the wrist joints in patients with rheumatoid arthritis treated with adalimumab. Ann Rheum Dis. 2006 Nov;65(11):1433-7.; Naredo E, Bonilla G, Gamero F, et al. Assessment of inflammatory activity in rheumatoid arthritis: a comparative study of clinical evaluation with grey scale and power Doppler ultrasonography. Ann Rheum Dis. 2005;64:375-81. doi:10.1136/ard.2004.023929; Hameed B, Pilcher J, Heron C, et al. The relation between composite ultrasound measures and the DAS 28 score, its components and acute phase markers in adult RA. Rheumatology. 2008;47:47680. doi:10.1093/rheumatology/kem383; Scire CA, Montecucco C, Codullo V, et al. Ultrasonographic evaluation of joint involvement in early rheumatoid arthritis in clinical remission: power Doppler signal predicts short-term relapse. Rheumatology. 2009;48:1092-7. doi:10.1093/rheumatology/kep171; Vlad V, Berghea F, Libianu S, et al. Ultrasound in rheumatoid arthritis – volar versus dorsal synovitis evaluation and scoring. BMC Musculoskelet Disord. 2011;12:124. doi:10.1186/1471-2474-12-124; Dejaco C, Duftner C, Wipfler-Freissmuth E, et al. Elderly-versus younger-onset rheumatoid arthritis: Higher levels of ultrasounddetected inflammation despite comparable clinical disease activity. Arthritis Care Res. 2013;65:304-8. doi:10.1002/acr.21823; Naredo E, Collado P, Cruz A, et al. Longitudinal Power Doppler Ultrasonographic Assessment of Joint Inflammatory Activity in Early Rheumatoid Arthritis: Predictive Value in Disease Activity and Radiologic Progression. Arthritis Care Res. 2007;57(1):116-24. doi:10.1002/art.22461; Ikeda K, Nakagomi D, Sanayama Y, et al. Correlation of radiographic progression with the cumulative activity of synovitis estimated by power Doppler ultrasound in rheumatoid arthritis: difference between patients treated with methotrexate and those treated with biological agents. J Rheumatol. 2013 Dec;40(12):1967-76. doi:10.3899/jrheum.130556. Epub 2013 Nov 1.; Geng Y, Han J, Deng X, Zhang Z. Presence of power Doppler synovitis in rheumatoid arthritis patients with synthetic and/or biological disease-modifying anti-rheumatic drug-induced clinical remission: experience from a Chinese cohort. Clin Rheumatol. 2014 Aug;33(8):1061-6. doi:10.1007/s10067-014-2634-y. Epub 2014 Apr 29.; Zufferey P, Brulhart L, Tamborrini G, et al. Ultrasound evaluation of synovitis in RA: correlation with clinical disease activity and sensitivity to change in an observational cohort study. Joint Bone Spine. 2014 May;81(3):222-7. doi:10.1016/j.jbspin.2013.08.006. Epub 2013 Nov 5.; Harman H, Tekeoglu I, Takci S, et al. Improvement of large-joint ultrasonographic synovitis is delayed in patients with newly diagnosed rheumatoid arthritis: results of a 12-month clinical and ultrasonographic follow-up study of a local cohort. Clin Rheumatol. 2015 Aug;34(8):1367-74. doi:10.1007/s10067-0152926-x. Epub 2015 Apr 2.; Cerqueira M, Teixeira F, Sousa Neves J, et al. Relationship between clinical evaluation and ultrasound assessment of rheumatoid arthritis patients using a 12 joint score. Int J Rheum Dis. 2017;20:852-8. doi:10.1111/1756-185X.13005; Terslev L, Torp-Pedersen S, Qvistgaard E, et al. Effects of treatment with etanercept (Enbrel, TNRF:Fc) on rheumatoid arthritis evaluated by Doppler ultrasonography. Ann Rheum Dis. 2003;62:178-81. doi:10.1136/ard.62.2.178; Backhaus M, Ohrndorf S, Kellner H, et al. Evaluation of a novel 7-joint ultrasound score in daily rheumatologic practice: A pilot project. Arthritis Rheum. 2009;61:1194-201. doi:10.1002/art.24646; Iagnocco A, Filippucci E, Perella C, et al. Clinical and ultrasonographic monitoring of response to adalimumab treatment in rheumatoid arthritis. J Rheumatol. 2008;35:35-40.; Kane D, Balint PV, Sturrock RD. Ultrasonography is superior to clinical examination in the detection and localization of knee joint effusion in rheumatoid arthritis. J Rheumatol. 2003 May;30(5):966-71.; Backhaus M, Kamradt T, Sandrock D, et al. Arthritis of the finger joints: A comprehensive approach comparing conventional radiography, scintigraphy, ultrasound, and contrast-enhanced magnetic resonance imaging. Arthritis Rheum. 1999;42:1232-45. doi:10.1002/1529-0131(199906)42:63.0.CO;2-3; Qvistgaard E, Rogind H, Torp-Pedersen S, et al. Quantitative ultrasonography in rheumatoid arthritis: evaluation of inflammation by Doppler technique. Ann Rheum Dis. 2001;60:690-3. doi:10.1136/ard.60.7.690; Hammer HB, Kvien TK, Terslev L. Ultrasound of the hand is sufficient to detect subclinical inflammation in rheumatoid arthritis remission: a post hoc longitudinal study. Arthritis Res Ther. 2017;19:221. doi:10.1186/s13075-017-1428-4; Fukae J, Isobe M, Kitano A, et al. Positive synovial vascularity in patients with low disease activity indicates smouldering inflammation leading to joint damage in rheumatoid arthritis: time-integrated joint inflammation estimated by synovial vascularity in each finger joint. Rheumatology. 2013;52:523-8. doi:10.1093/rheumatology/kes310; Iagnocco A, Finucci A, Ceccarelli F, et al. Power Doppler ultrasound monitoring of response to anti-tumour necrosis factor alpha treatment in patients with rheumatoid arthritis. Rheumatology (Oxford). 2015 Oct;54(10):1890-6. doi:10.1093/rheumatology/kev211; Smolen JS, Landewe R, Breedveld FC, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis. 2010;69(6):964-75. doi:10.1136/ard.2009.126532; Padovano I, Costantino F, Breban M, et al. Prevalence of ultrasound synovial inflammatory findings in healthy subjects. Ann Rheum Dis. 2016;75:1819-23. doi:10.1136/annrheumdis-2015208103; D’Agostino MA, Terslev L, Wakefield R, et al. Novel algorithms for the pragmatic use of ultrasound in the management of patients with rheumatoid arthritis: from diagnosis to remission. Ann Rheum Dis. 2016;75:1902-8. doi:10.1136/annrheumdis-2016-209646; Freeston JE, Wakefield RJ, Conaghan PG, et al. A diagnostic algorithm for persistence of very early inflammatory arthritis: the utility of power Doppler ultrasound when added to conventional assessment tools. Ann Rheum Dis. 2010;69(2):417-9. doi:10.1136/ard.2008.106658; Foltz V, Gandjbakhch F, Etchepare F, et al. Power Doppler ultrasound, but not low-field magnetic resonance imaging, predicts relapse and radiographic disease progression in rheumatoid arthritis patients with low levels of disease activity. Arthritis Rheum. 2012;64(1):67-76. doi:10.1002/art.33312; Saleem B, Brown AK, Quinn M, et al. Can flare be predicted in DMARD treated RA patients in remission, and is it important? A cohort study. Ann Rheum Dis. 2012 Aug;71(8):1316-21. doi:10.1136/annrheumdis-2011-200548; Kawashiri S, Fujikawa K, Nishino A, et al. Ultrasound-detected bone erosion is a relapse risk factor after discontinuation of biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis whose ultrasound power Doppler synovitis activity and clinical disease activity are well controlled. Arthritis Res Ther. 2017;19:108. doi:10.1186/s13075-017-1320-2; Alivernini S, Peluso G, Fedele AL, et al. Tapering and discontinuation of TNF-α blockers without disease relapse using ultrasonography as a tool to identify patients with rheumatoid arthritis in clinical and histological remission. Arthritis Res Ther. 2016;18:39. doi:10.1186/s13075-016-0927-z; Iwamoto T, Ikeda K, Hosokawa J, et al. Prediction of Relapse After Discontinuation of Biologic Agents by Ultrasonographic Assessment in Patients With Rheumatoid Arthritis in Clinical Remission: High Predictive Values of Total Gray-Scale and Power Doppler Scores That Represent Residual Synovial Inflammation Before Discontinuation. Arthritis Care Res. 2014;66:1576-81. doi:10.1002/acr.22303; Peluso G, Michelutti A, Bosello S, et al. Clinical and ultrasonographic remission determines different chances of relapse in early and long standing rheumatoid arthritis. Ann Rheum Dis. 2011;70:172-5. doi:10.1136/ard.2010.129924; Lamers-Karnebeek FB, Luime JJ, Ten Cate DF, et al. Limited value for ultrasonography in predicting flare in rheumatoid arthritis patients with low disease activity stopping TNF inhibitors. Rheumatology. 2017 Sep;56(9):1560-5. doi:10.1093/rheumatology/kex184; Marks DJ, Holroyd DC, Dimitrov DB, et al. Does combined clinical and ultrasound assessment allow selection of individuals with rheumatoid arthritis for sustained reduction of anti-TNF therapy? Arthritis Care Res. 2015;67(6):746-53. doi:10.1002/acr.22552; Taylor PC, Steuer A, Gruber J, et al. Comparison of ultrasonographic assessment of synovitis and joint vascularity with radiographic evaluation in a randomized, placebo-controlled study of infliximab therapy in early rheumatoid arthritis. Arthritis Rheum. 2004;50:1107-16. doi:10.1002/art.20123; Naredo E, Müller I, Cruz A, et al. Power doppler ultrasonographic monitoring of response to anti-tumor necrosis factor therapy in patients with rheumatoid arthritis. Arthritis Rheum. 2008;58:224856. doi:10.1002/art.23682; Brown AK, Conaghan PG, Karim Z, et al. An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis. Arthritis Rheum. 2008;58:2958-67. doi:10.1002/art.23945; Dougados M, Devauchelle-Pensec V, Ferlet JF, et al. The ability of synovitis to predict structural damage in rheumatoid arthritis: a comparative study between clinical examination and ultrasound. Ann Rheum Dis. 2013;72(5):665-71. doi:10.1136/annrheumdis2012-201469; Funck-Brentano T, Gandjbakhch F, Etchepare F, et al. Prediction of radiographic damage in early arthritis by sonographic erosions and power Doppler signal: a longitudinal observational study. Arthritis Care Res (Hoboken). 2013 Jun;65(6):896-902. doi:10.1002/acr.21912; Dale J, Stirling A, Zhang R, et al Targeting ultrasound remission in early rheumatoid arthritis: the results of the TaSER study, a randomised clinical trial. Ann Rheum Dis. 2016 Jun;75(6):1043-50. doi:10.1136/annrheumdis-2015-208941. Epub 2016 Mar 29.; Tokai N, Ogasawara M, Gorai M, et al. Predictive value of bone destruction and duration of clinical remission for subclinical synovitis inrheumatoid arthritis patients. Mod Rheumatol. 2015 Jul;25(4):540-5. doi:10.3109/14397595.2014.987421. Epub 2014 Dec 15.; Hama M, Uehara T, Takase K, et al. Power Doppler ultrasonography is useful for assessing disease activity and predicting joint destruction in rheumatoid arthritis patients receiving tocilizumab – preliminary data. Rheumatol Int. 2012;32(5):132733. doi:10.1007/s00296-011-1802-5; Vreju FA, Filippucci E, Gutierrez M, et al. Subclinical ultrasound synovitis in a particular joint is associated with ultrasound evidence of bone erosions in that same joint in rheumatoid patients in clinical remission. Clin Exp Rheumatol. 2016 Jul-Aug;34(4):673-8. Epub 2016 May 9.; Kirino Y, Hama M, Takase-Minegishi K, et al. Predicting joint destruction in rheumatoid arthritis with power Doppler, anti-citrullinated peptide antibody, and joint swelling. Mod Rheumatol. 2015;25(6):842-8. doi:10.3109/14397595.2015.1026025. Epub 2015 Apr 30.; Sreerangaiah D, Grayer M, Fisher BA, et al. Quantitative power Doppler ultrasound measures of peripheral joint synovitis in poor prognosis early rheumatoid arthritis predict radiographic progression. Rheumatology. 2016;55(1):89-93. doi:10.1093/rheumatology/kev305; Naredo E, Rodriguez M, Campos C, et al. Validity, reproducibility, and responsiveness of a twelve-joint simplified power Doppler ultrasonographic assessment of joint inflammation in rheumatoid arthritis. Arthritis Rheum. 2008;59:515-22. doi:10.1002/art.23529; Ventura-Rios L, Hernandez-Diaz C, Ferrusquia-Toriz D, et al; Grupo Mexicano de Ecografia Musculoesquelitica AC (ECOMER). Reliability of ultrasound grading traditional score and new global OMERACT-EULAR score system (GLOESS): results from an inter- and intra-reading exercise by rheumatologists. Clin Rheumatol. 2017 May 5. doi:10.1007/s10067-017-3662-1; D’Agostino M-A, Wakefield RJ, Berner-Hammer H, et al. Value of ultrasonography as a marker of early response to abatacept in patients with rheumatoid arthritis and an inadequate response to methotrexate: results from the APPRAISE study. Ann Rheum Dis. 2016;75(10):1763-9. doi:10.1136/annrheumdis-2015-207709; Kitchen J, Kane D. Greyscale and power Doppler ultrasonographic evaluation of normal synovial joints: correlation with pro- and anti-inflammatory cytokines an angiogenic factors. Rheumatology (Oxford). 2015;54:458-62. doi:10.1093/rheumatology/keu354; Ellegaard K, Torp-Pedersen S, Holm CC, et al. Ultrasound in finger joints: findings in normal subjects and pitfalls in the diagnosis of synovial disease. Ultraschall Med. 2007;28:401-8. doi:10.1055/s-2007-963170; Caporali R, Smolen JS. Back to the future: forget ultrasound and focus on clinical assessment in rheumatoid arthritis management. Ann Rheum Dis. 2018;77:18-20. doi:10.1136/annrheumdis-2017211458. [Pub. Online 02 Aug 2017].; Colebatch AN, Edwards CJ, Ostergaard M, et al. EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis. Ann Rheum Dis. 2013;72:804-14. doi:10.1136/annrheumdis-2012-203158

Διαθεσιμότητα: https://rsp.mediar-press.net/rsp/article/view/2504
https://doi.org/10.14412/1995-4484-2018-82-92

ASSOCIATION BETWEEN ULTRASOUND SIGNS OF JOINT INFLAMMATION AND RADIOGRAPHIC PROGRESSION IN PATIENTS WITH RHEUMATOID ARTHRITIS ; Взаимосвязь ультразвуковых признаков воспаления суставов и рентгенологического прогрессирования у пациентов с ревматоидным артритом

Συγγραφείς: O. G. Alekseeva, M. V. Severinova, A. V. Smirnov, N. V. Demidova, E. N. Aleksandrova, A. A. Novikov, E. L. Luchikhina, D. E. Karateev, S. I. Glukhova, A. V. Volkov, E. L. Nasonov, О. Г. Алексеева, М. В. Северинова, А. В. Смирнов, Н. В. Демидова, Е. Н. Александрова, А. А. Новиков, Е. Л. Лучихина, Д. Е. Каратеев, С. И. Глухова, А. В. Волков, Е. Л. Насонов

Πηγή: Rheumatology Science and Practice; Vol 54, No 3 (2016); 304-311 ; Научно-практическая ревматология; Vol 54, No 3 (2016); 304-311 ; 1995-4492 ; 1995-4484 ; 10.14412/rsp20163

Θεματικοί όροι: рентгенологическое прогрессирование, joint ultrasound study, radiographic progression, ультразвуковое исследование суставов

Περιγραφή αρχείου: application/pdf

Relation: https://rsp.mediar-press.net/rsp/article/view/2223/1439; Smolen JS, Aletaha D, Bijsma JW, et al, for the T2T Expert Committee. Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis. 2010;69:631-7. doi:10.1136/ard.2009.123919; Quinn MA, Emery P. Window of opportunity in early rheumatoid arthritis: possibility of altering the disease process with early intervention. Clin Exp Rheumatol. 2003;21 Suppl 31:S154-7.; Mottonen T, Hannonen P, Korpela M, et al. Delay to institution of therapy and induction of remission using single-drug or combination-disease-modifying antirheumatic drug therapy in early rheumatoid arthritis. Arthritis Rheum. 2002;46:894-8. doi:10.1002/art.10135; Ostergaard M, Pedersen SJ, Dohn UM. Imaging in rheumatoid arthritis – status and recent advances for magnetic resonance imaging, ultrasonography, computed tomography and conventional radiography. Best Pract Res Clin Rheumatol. 2008;22:1019-44. doi:10.1016/j.berh.2008.09.014; Anderson J, Zimmerman L, Caplan L, Michaud K. Measures of rheumatoid arthritis disease activity. Arthritis Care Res. 2011;63(11):S14-36. doi:10.1002/acr.20621; De Jong P, Hazes J, van Zeben D, et al. Treatment decisions and related costs differ significantly depending on the choice of a disease activity index in RA, according to 1987 and 2010 classification criteria. Rheumatology. 2012;51:1269-77. doi:10.1093/rheumatology/kes00; Marks DJ, Holroyd DC, Dimitrov DB, et al. Does combined clinical and ultrasound assessment allow selection of individuals with rheumatoid arthritis for sustained reduction of anti-TNF therapy? Arthritis Care Res. 2015;67(6):746-53. doi:10.1002/acr.22552; Zhang LY, Xiang X, Tang YJ, et al. Correlation between quantitative results of contrast-enhanced ultrasonography and clinical and laboratory indexes for synovium of patients with rheumatoid arthritis. Sichuan Da Xue Xue Bao Yi Xue Ban. 2014 Nov;45(6):1001-4.; Colebatch AN, Edwards CJ, Ostergaard M, et al. EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis. Ann Rheum Dis. 2013;72:804-14. doi:10.1136/annrheumdis-2012-203158; Filippucci Е, Iagnocco А, Salaffi F, et al. Power Doppler sonography monitoring of synovial perfusion at the wrist joints in patients with rheumatoid arthritis treated with adalimumab. Ann Rheum Dis. 2006 Nov;65(11):1433-7.; Taylor PC, Steuer A, Gruber J, et al. Comparison of ultrasonographic assessment of synovitis and joint vascularity with radiographic evaluation in a randomized, placebo-controlled study of infliximab therapy in early rheumatoid arthritis. Arthritis Rheum. 2004;50(4):1107-16. doi:10.1002/art.20123; Каратеев ДЕ, Лучихина ЕЛ, Муравьев ЮВ и др. Первое российское стратегическое исследование фармакотерапии ревматоидного артрита (РЕМАРКА). Научно-практическая ревматология. 2013;51(2):117-25 [Karateev DE, Luchikhina EL, Muravyev YuV, et al. The first Russian strategic study of pharmacotherapy for rheumatoid arthritis (REMARCA). NauchnoPrakticheskaya Revmatologiya = Rheumatology Science and Practice. 2013;51(2):117-25. (In Russ.)]. doi:10.14412/1995-4484-2013-637; Каратеев ДЕ, Лучихина ЕЛ, Демидова НВ и др. Первое российское стратегическое исследование фармакотерапии ревматоидного артрита (РЕМАРКА): результаты лечения 130 больных в течение 12 месяцев. Научно-практическая ревматология. 2014;52(6):607-14 [Karateev DE, Luchikhina EL, Demidova NV, et al. The first Russian strategic study of pharmacotherapy for rheumatoid arthritis (REMARCA trial): Results of 12-month treatment in 130 patients. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2014;52(6):607-14 (In Russ.)]. doi:10.14412/1995-4484-2014-607-614; Алексеева ОГ, Новиков АА, Северинова МВ и др. Динамика уровня биомаркеров и ультразвуковые признаки воспаления у пациентов с ревматоидным артритом. Научно-; практическая ревматология. 2015;53(5):485-92 [Alekseeva OG, Novikov AA, Severinova MV, et al. The time course of changes in biomarker levels and the ultrasonic signs of inflammation in patients with rheumatoid arthritis. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2015;53(5):485-92 (In Russ.)]. doi:10.14412/1995-4484-2015-485-492; Алексеева ОГ, Северинова МВ, Демидова НВ и др. Связь клинических проявлений и ультразвуковых признаков воспаления у пациентов с ревматоидным артритом. Научно-практическая ревматология. 2015;53(6):596-602 [Alekseeva OG, Severinova MV, Demidova NV, et al. Association between clinical manifestations and ultrasonic signs of inflammation in patients with rheumatoid arthritis. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2015;53(6):596-602 (In Russ.)]. doi:10.14412/1995-4484-2015-596-602; Fransen J, Stucki G, van Reil PLCM. Rheumatoid arthritis measures. Arthritis Rheum. 2003;49:214-24. doi:10.1002/art.11407; Aletaha D, Nell V, Stamm T, et al. Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score. Arthritis Res Ther. 2005;7(4):R796-806. doi:10.1186/ar1740; Wakefield R, Balint P, Szkudlarek M, et al. Musculoskeletal ultrasound including definitions for ultrasonographic pathology. J Rheumatol. 2005;32:2485-7.; Scheel AK, Hermann K-GA, Kahler E, et al. A novel ultrasonographic synovitis scoring system suitable for analyzing finger joint inflammation in rheumatoid arthritis. Arthritis Rheum. 2005;52:733-43. doi:10.1002/art.20939; Van der Heijde D. How to read radiographs according to the Sharp/van der Heijde method. J Rheumatol. 1999;26:743-5.; Смирнов АВ. Атлас рентгенологической диагностики ревматоидного артрита. Москва: ИМА-ПРЕСС; 2009 [Smirnov AV. Atlas rentgenologicheskoi diagnostiki revmatoidnogo artrita [Atlas of radiographic diagnosis of rheumatoid arthritis]. Moscow: IMA-PRESS; 2009].; Naredo E, Collado P, Cruz A, et al. Longitudinal power Doppler ultrasonographic assessment of joint inflammatory activity in early rheumatoid arthritis: predictive value in disease activity and radiologic progression. Arthritis Rheum. 2007;57:116-24. doi:10.1002/art.22461; Brown AK, Conaghan PG, Karim Z, et al. An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis. Arthritis Rheum. 2008;58(10):2958-67. doi:10.1002/art.23945; Foltz V, Gandjbakhch F, Etchepare F, et al. Power Doppler ultrasound, but not low-field magnetic resonance imaging, predicts relapse and radiographic disease progression in rheumatoid arthritis patients with low levels of disease activity. Arthritis Rheum. 2012;64(1):67-76. doi:10.1002/art.33312; Ikeda K, Nakagomi D, Sanayama Y, et al. Correlation of radiographic progression with the cumulative activity of synovitis estimated by power Doppler ultrasound in rheumatoid arthritis: difference between patients treated with methotrexate and those treated with biological agents. J Rheumatol. 2013 Dec;40(12):1967-76. doi:10.3899/jrheum.130556. Epub 2013 Nov 1.; Dougados M, Devauchelle-Pensec V, Ferlet J, et al. The ability of synovitis to predict structural damage in rheumatoid arthritis: a comparative study between clinical examination and ultrasound. Ann Rheum Dis. 2013;72:665-71. doi:10.1136/annrheumdis-2012-201469; Naredo E, Valor L, de la Torre I, et al. Predictive value of Doppler ultrasound-detected synovitis in relation to failed tapering of biologic therapy in patients with rheumatoid arthritis. Rheumatology (Oxford). 2015 Aug;54(8):1408-14. doi:10.1093/rheumatology/kev006; Funck-Brentano T, Gandjbakhch F, Etchepare F, et al. Prediction of radiographic damage in early arthritis by sonographic erosions and power Doppler signal: a longitudinal observational study. Arthritis Care Res (Hoboken). 2013 Jun;65(6):896-902. doi:10.1002/acr.21912; Dale J, Stirling A, Zhang R, et al. Targeting ultrasound remission in early rheumatoid arthritis: the results of the TaSER study, a randomised clinical trial. Ann Rheum Dis. 2016;0:1-8. doi:10.1136/annrheumdis-2015-208941; Nguyen H, Ruyssen-Witrand A, Gandjbakhch F, et al. Prevalence of ultrasound-detected residual synovitis and risk of relapse and structural progression in rheumatoid arthritis patients in clinical remission: a systematic review and meta-analysis. Rheumatology. 2014;53:2110-8. doi:10.1093/rheumatology/keu217; Осипянц РА, Каратеев ДЕ, Панасюк ЕЮ и др. Оценка эффективности терапии тоцилизумабом у пациентов с ревматоидным артритом по данным ультразвукового исследования и рентгенографии. Научно-практическая ревматология. 2013;51(1):38-43 [Osipyants RA, Karateev DE, Panasyuk EYu, et al. Evaluation of the efficiency of tocilizumab therapy in patients with rheumatoid arthritis by ultrasound and X-ray data. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2013;51(1):38-43 (In Russ.)]. doi:10.14412/1995-4484-2013-1199; Fukae J, Isobe M, Kitano A, et al. Positive synovial vascularity in patients with low disease activity indicates smouldering inflammation leading to joint damage in rheumatoid arthritis: time-integrated joint inflammation estimated by synovial vascularity in each finger joint. Rheumatology. 2013;52:523-8. doi:10.1093/rheumatology/kes310; Harman H, Tekeoglu I, Takci S, et al. Improvement of large-joint ultrasonographic synovitis is delayed in patients with newly diagnosed rheumatoid arthritis: results of a 12-month clinical and ultrasonographic follow-up study of a local cohort. Clin Rheumatol. 2015 Aug;34(8):1367-74. doi:10.1007/s10067-015-2926-x. Epub 2015 Apr 2.

Διαθεσιμότητα: https://rsp.mediar-press.net/rsp/article/view/2223
https://doi.org/10.14412/1995-4484-2016-304-311

ВЗАИМОСВЯЗЬ УЛЬТРАЗВУКОВЫХ ПРИЗНАКОВ ВОСПАЛЕНИЯ СУСТАВОВ И РЕНТГЕНОЛОГИЧЕСКОГО ПРОГРЕССИРОВАНИЯ У ПАЦИЕНТОВ С РЕВМАТОИДНЫМ АРТРИТОМ

Συγγραφείς: АЛЕКСЕЕВА О.Г., СЕВЕРИНОВА М.В., СМИРНОВ А.В., ДЕМИДОВА Н.В., АЛЕКСАНДРОВА Е.Н., НОВИКОВ А.А., ЛУЧИХИНА Е.Л., КАРАТЕЕВ Д.Е., ГЛУХОВА С.И., ВОЛКОВ АЛЕКСАНДР ВИТАЛЬЕВИЧ, НАСОНОВ Е.Л.

Θεματικοί όροι: РЕВМАТОИДНЫЙ АРТРИТ,УЛЬТРАЗВУКОВОЕ ИССЛЕДОВАНИЕ СУСТАВОВ,РЕНТГЕНОЛОГИЧЕСКОЕ ПРОГРЕССИРОВАНИЕ,RHEUMATOID ARTHRITIS,JOINT ULTRASOUND STUDY,RADIOGRAPHIC PROGRESSION

Περιγραφή αρχείου: text/html

Διαθεσιμότητα: http://cyberleninka.ru/article/n/vzaimosvyaz-ultrazvukovyh-priznakov-vospaleniya-sustavov-i-rentgenologicheskogo-progressirovaniya-u-patsientov-s-revmatoidnym
http://cyberleninka.ru/article_covers/17022539.png

FAKTORY PROGRESSIROVANIYa OSTEOARTROZA KOLENNYKh SUSTAVOV (5-letnee prospektivnoeNABLYuDENIE)

Συγγραφείς: N G KAShEVAROVA, E M ZAYTsEVA, O V PUShKOVA, A V SMIRNOV, L I ALEKSEEVA

Πηγή: Остеопороз и остеопатии, Vol 16, Iss 2, Pp 9-11 (2013)

Θεματικοί όροι: остеоартроз коленных суставов, интенсивная боль, синовит, рентгенологическое прогрессирование, Osteopathy, RZ301-397.5

Περιγραφή αρχείου: electronic resource

Relation: https://endojournals.ru/index.php/osteo/article/view/8852; https://doaj.org/toc/2072-2680; https://doaj.org/toc/2311-0716

Σύνδεσμος πρόσβασης: https://doaj.org/article/b14032bb592d4d328374a059f14ec633

EFFICACY OF INFLIXIMAB IN RHEUMATOID ARTHRITIS: A RELATIONSHIP TO THE TOTAL DOSE OF THE DRUG ; Эффективность инфликсимаба при ревматоидном артрите – зависимость от суммарной дозы препарата

Συγγραφείς: E. S. Aronova, G. V. Lukina, Ya. A. Sigidin, Е. С. Аронова, Г. В. Лукина, Я. А. Сигидин

Πηγή: Rheumatology Science and Practice; Vol 53, No 5 (2015); 506-511 ; Научно-практическая ревматология; Vol 53, No 5 (2015); 506-511 ; 1995-4492 ; 1995-4484 ; 10.14412/rsp20155

Θεματικοί όροι: рентгенологическое прогрессирование, adverse reactions, rheumatoid arthritis, radiographic progression, нежелательные реакции, ревматоидный артрит

Περιγραφή αρχείου: application/pdf

Relation: https://rsp.mediar-press.net/rsp/article/view/2128/1354; Насонов ЕЛ. Применение инфликсимаба (моноклональные антитела к фактору некроза опухоли α) в ревматологии: новые факты и идеи. Русский медицинский журнал. 2004;(12):1123–7 [Nasonov EL. The use of infliximab (monoclonal antibody to tumor necrosis factor α) in rheumatology, new facts and ideas. Russkii meditsinskii zhurnal. 2004;(12):1123–7 (In Russ.)].; Maini RN, Breedveld FC, Kalden JR, et al. Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients withrheumatoid arthritis treated with infliximab and methotrexate. Arthritis Rheum. 2004;50:1051–65. doi:10.1002/art.20159; Nam J, Emery P. Aspects of TNF inhibitor therapy in rheumatoid arthritis. Mod Rheumatol. 2010 Aug;20(4):325–30. doi:10.1007/s10165-010-0277-7. Epub 2010 Mar 2.; Ackermann C, Kavanaugh A. Tumor necrosis factor as a therapeutic target of rheumatologic disease. Expert Opin Ther Targets. 2007 Nov;11:1369–84. doi:10.1517/14728222.11.11.1369; Karampetsou MP, Liossis SN, Sfikakis PP. TNF-{alpha} antagonists beyond approved indications: stories of success and prospects for the future. QJM. 2010 Dec;103(12):917–28. doi:10.1093/qjmed/hcq152; Taylor PC. Pharmacology of TNF blockade in rheumatoid arthritis and other chronic inflammatory diseases. Curr Opin Pharmacol. 2010 Jun;10(3):308–15. doi:10.1016/j.coph.2010.01.005; Arif S, Cox P, Afzali B, et al. Anti-TNFα therapy: killing two birds with one stone? Lancet. 2010;375:2278. doi:10.1016/S0140-6736(10)60394-7; Scott DL, Kingsley G. Clinical effectiveness of biologics in clinical practice. Arthritis Res Ther. 2010 Apr 28;12(2):115. doi:10.1186/ar2970 [Epub ahead of print].; Мазуров ВИ, Лила АМ, Жугрова ЕС. Опыт применения Ремикейда при некоторых аутоиммунных заболеваниях. Русский медицинский журнал. 2004;13:700–3 [Mazurov I; Lila AM, Zhugrova ES. Experience in the use of Remicade in certain autoimmune diseases. Russkii meditsinskii zhurnal. 2004;13:700–3 (In Russ.)].; Коршунов НИ. Ревматоидный артрит: диагностика и лечение. Русский медицинский журнал. 2005;14:956–63 [Korshunov NI. Rheumatoid arthritis: diagnosis and treatment. Russkii meditsinskii zhurnal. 2005;14:956–63 (In Russ.)].; Elliot MJ, Maini RN, Feldmann M, et al. Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α. Arthritis Rheum. 1993;36:1681–90. doi:10.1002/art.1780361206; Elliot MJ, Maini RN, Feldmann M, et al. Repeated therapy with monoclonal antibody to tumor necrosis factor α (cA2) in patients with rheumatoid arthritis. Lancet. 1994;344:1125–7. doi:10.1016/S0140-6736(94)90632-7; Breedveld FC, Emery P, Keystone E, et al. Infliximab in active early rheumatoid arthritis. Ann Rheum Dis. 2004;63:149–55. doi:10.1136/ard.2003.013961; Van der Bijl AE, Goekoop-Ruiterman YP, Breedveld FC, et al. Many early rheumatoid arthritis patients with a good clinical response to infliximab can discontinue anti-TNF-alpha therapy without relapse. Ann Rheum Dis. 2005;64(Suppl III):59.; Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF, et al. Comparison of treatment strategies in early rheumatoid arthritis: a randomized trial. Ann Intern Med. 2007;146:406–15. doi:10.7326/0003-4819-146-6-200703200-00005; Maini R, Patel K, Baker D, et al. Treatment with infliximab and methotrexate leads to healing of joint erosion in patients with rheumatoid arthritis. Ann Rheum Dis. 2003;62(Suppl 1):97.; Kanayama Y, Kojima T, Hirano Y, et al. Radiographic progression of cervical lesions in patients with rheumatoid arthritis receiving infliximab treatment. Mod Rheumatol. 2010 Jun;20(3):273–9. doi:10.1007/s10165-010-0276-8. Epub 2010 Feb 19.; Takeuchi T, Yamanaka H, Inoue E, et al. Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan: oneyear outcome of joint destruction (RECONFIRM-2J). Mod Rheumatol. 2008 May 21. doi:10.3109/s10165-008-0077-5; Pavelka K, Gatterova J, Tegzova D, et al. Radiographic progression of rheumatoid arthritis in patients from the Czech National Registry receiving infliximab treatment. Clin Exp Rheumatol. 2007 Jul-Aug;25(4):540–5.; Gü ler-Yü ksel M, Allaart CF, Watt I, et al. Treatment with TNFalpha inhibitor infliximab might reduce hand osteoarthritis in patients with rheumatoid arthritis. Osteoarthritis Cartilage. 2010 Oct;18(10):1256–62. doi:10.1016/j.joca.2010.07.011; Van der Kooij SM, Goekoop-Ruiterman YPM, de Vries-Bouwstra JK, et al. Drug-free remission, functioning and radiographic damage after 4 years of response-driven treatment in patients with recent onset rheumatoid arthritis. Ann Rheum Dis. 2008 28 Jul. doi:10.1136/ard.2008092254; Smolen JS, Han C, van der Heijde DM, et al. Radiographic changes in rheumatoid arthritis patients attaining different disease activity states with methotrexate monotherapy and infliximab plus methotrexate: the impacts of remission and TNF-blocade. Ann Rheum Dis. 2008; Jul 7 [Epub ahead of print].; Quinn MA, Conaghan PG, Greenstein A, et al. Sustained response in early poor prognosis RA after withdrawal of infliximab therapy. Arthritis Rheum. 2002;46:3416.; Bejarano V, Conaghan PG, Quinn MA, et al. 8 years after a remission induction regime with an infliximab and methotrexate combination in early rheumatoid arthritis. Rheumatology (Oxford). 2010 Oct;49(10):1971–4. doi:10.1093/rheumatology/keq194; Tanaka Y, Takeuchi T, Mimori T, et al. for the RRR study investigators. Discontinuation of infliximab after attaining low disease activity in patients with rheumatoid arthritis: RRR (remission induction by Remicade in RA) study. Ann Rheum Dis. 2010 Jul;69(7):1286–91. doi:10.1136/ard.2009.121491. Epub 2010 Apr 1.; Van den Broek M, Klarenbeek NB, Dirven L, et al. Discontinuation of infliximab and potential predictors of persistent low disease activity in patients with early rheumatoid arthritis and disease activity score-steered therapy: subanalysis of the BeSt study. Ann Rheum Dis. 2011;70:1389–94. doi:10.1136/ard.2010.147751.

Διαθεσιμότητα: https://rsp.mediar-press.net/rsp/article/view/2128
https://doi.org/10.14412/1995-4484-2015-506-511

Efficacy of golimumab in the treatment of patients with ankylosing spondylitis (according to the data of a long-term follow-up) ; Эффективность голимумаба в лечении больных анкилозирующим спондилитом (по данным длительного наблюдения)

Συγγραφείς: A. V. Smirnov, T. V. Dubinina, Sh. F. Erdes, Александр Викторович Смирнов, Т. В. Дубинина, Ш. Ф. Эрдес

Πηγή: Modern Rheumatology Journal; Том 9, № 1 (2015); 72-77 ; Современная ревматология; Том 9, № 1 (2015); 72-77 ; 2310-158X ; 1996-7012 ; 10.14412/1996-7012-2015-1

Θεματικοί όροι: голимумаб, structural changes, X-ray progression, golimumab, структурные изменения, рентгенологическое прогрессирование

Περιγραφή αρχείου: application/pdf

Relation: https://mrj.ima-press.net/mrj/article/view/602/588; Smolen JS, Braun J, Dougados M, et al. Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force. Ann Rheum Dis. 2014 Jan;73(1):6–16. doi:10.1136/annrheumdis-2013-203419. Epub 2013 Jun 8.; Эрдес ШФ. Основные принципы терапии анкилозирующего спондилита (болезни Бехтерева). Научно-практическая ревматология. 2013;51(6):686–95. [Erdes ShF. The basic principles of treatment of ankylosing spondylitis (Bechterev’s disease). Nauchno-prakticheskaya revmatologiya = Rheumatology Science and Practice. 2013;51(6):686–95. (In Russ.).] DOI:http://dx.doi.org/10.14412/1995-4484-2013-686-95.; Насонов ЕЛ. Эффективность и безопасность ингибиторов фактора некроза опухоли α при ревматоидном артрите. Русский Медицинский Журнал. 2008;(24):1602–609. [Nasonov EL. The efficacy and safety of inhibitors of tumor necrosis factor α in rheumatoid arthritis. Russkii Meditsinskii Zhurnal. 2008;(24):1602–609. (In Russ.).]; Эрдес ШФ. Возможности голимумаба в терапии анкилозирующего спондилита. Современная ревматология. 2014;(3):77–81. [Erdes ShF. The abilities of golimumab in the therapy of ankylosing spondylitis. Sovremennaya revmatologiya = Modern Rheumatology Journal. 2014;(3):77–81. (In Russ.).] DOI: http://dx.doi.org/10.14412/1996-7012-2014-3-77-81; Tracey D, Klareskog L, Sasso EH, et al. Tumor necrosis factor antagonist mechanisms of action: a comprehensive review. Pharmacol Ther. 2008 Feb;117(2):244–79. Epub 2007 Oct 26. DOI: http://doi.org/10.1016/j.pharmthera.2007.10.001.; Deodhar A, Braun J, Inman RD, et al. Golimumab administered subcutaneously every 4 weeks in ankylosing spondylitis: 5-year results of the GO-RAISE study. Ann Rheum Dis. 2015 Apr;74(4):757-61. doi:10.1136/annrheumdis-2014-205862. Epub 2014 Nov 11.; Inman RD, Davis JC, van der Heijde D, et al. Efficacy and safety of golimumab in patients with ankylosing spondylitis. results of a randomized, double-blind, placebo-controlled, phase III trial. Arthritis Rheum. 2008 Nov;58(11):3402–12. doi:10.1002/art.23969.; Wagner C, Visvanathan S, Braun J, et al. Serum markers associated with clinical improvement in patients with ankylosing spondylitis treated with golimumab. Ann Rheum Dis. 2012 May;71(5):674–80. doi:10.1136/ard.2010.148890. Epub 2011 Oct 28.; Эрдес ШФ, Бочкова АГ, Дубинина ТВ и др. Ранняя диагностика анкилозирующего спондилита. Научно-практическая ревматология. 2013;51(4):365–67. [Erdes ShF, Bochkova AG, Dubinina TV, et al. Early diagnosis of ankylosing spondylitis. Nauchno-prakticheskaya revmatologiya = Rheumatology Science and Practice. 2013;51(4):365–67. (In Russ.).] DOI: http://dx.doi.org/10.14412/1995-4484-2013-1245; Baraliakos X, Hermann KG, Landewer R, et al. Assessment of acute spinal inflammation in patients with ankylosing spondylitis by magnetic resonance imaging: a comparison between contrast enhanced T1 and short tau inversion recovery (STIR) sequences. Ann Rheum Dis. 2005 Aug;64(8):1141–4. Epub 2005 Jan 13. doi:10.1136/ard.2004.031609.; Braun J, Baraliakos X, Golder W, et al. Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis, before and after successful therapy with infliximab: evaluation of a new scoring system. Arthritis Rheum. 2003 Apr;48(4):1126–36.; Creemers MC, Franssen MJ, van't Hof MA, et al. Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system. Ann Rheum Dis. 2005 Jan;64(1):127–9. Epub 2004 Mar 29.; van der Heijde D, Salonen D, Weissman BN, et al.; for the Canadian (M03-606) study group and the ATLAS study group. Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 years. Arthritis Res Ther. 2009;11(4):R127. doi:10.1186/ar2794. Epub 2009 Aug 24.; van der Heijde D, Landew R, Einstein S, et al. Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept. Arthritis Rheum. 2008 May;58(5):1324–31. doi:10.1002/art.23471.; van der Heijde D, Landew R, Baraliakos X, et al.; the Ankylosing Spondylitis Study for the Evaluation of Recombinant Infliximab Therapy Study Group. Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis. Arthritis Rheum. 2008 Oct;58(10):3063–70. doi:10.1002/art.23901.; Baraliakos X, Listing J, Brandt J, et al. Radiographic progression in patients with ankylosing spondylitis after 4 yrs of treatment with the anti-TNF- antibody infliximab. Rheumatology (Oxford). 2007 Sep;46(9):1450–3. Epub 2007 Jul 10.; Baraliakos X, Listing J, Rudwaleit M, et al. Progression of radiographic damage in patients with ankylosing spondylitis: defining the central role of syndesmophytes. Ann Rheum Dis. 2007 Jul;66(7):910–5. Epub 2007 Feb 28.; Смирнов АВ. Показатели рентгенологического пргрессирования и выраженности воспаления по результатам магнитно-резонансной томографии у больных ревматоидным артритом, анкилозирующим спондилитом и псориатическим артритом под влиянием терапии голимумабом.; Современная ревматология. 2013;(2):75–82. [Smirnov AV. Golimumab therapy-induced indicators of X-ray inflammation progression and magnitude according to magnetic resonance imaging evidence in patients with rheumatoid arthritis, ankylosing spondylitis, or psoriatic arthritis. Sovremennaya revmatologiya = Modern Rheumatology Journal. 2013;(2):75–82. (In Russ.)]. DOI: http://dx.doi.org/10.14412/1996-7012-2013-2387; Тюхова ЕЮ. Магнитно-резонансная томография позвоночника и крестцово-подвздошных суставов у больных спондилоартритами. Научно-практическая ревматология. 2012;51(2):106–11. [Tyukhova EYu. Magnetic resonance imaging of the spine and sacroiliac joints in patients with spondyloarthritis. Nauchno-prakticheskaya revmatologiya = Rheumatology Science and Practice. 2012;51(2):106–11. (In Russ.).] DOI: http://dx.doi.org/10.14412/1995-4484-2012-1282; Baraliakos X, Hermann KG, Xu S, et al. Spinal mobility in the cervical and the lumbar spine correlates with magnetic resonance imaging findings in patients with ankylosing spondylitis – more results from the GORAISE trial. Ann Rheum Dis 2014;73(Suppl2):730.; Haroon N, Maksymowych WP, Rahman P, et al. Radiographic severity of ankylosing spondylitis is associated with polymorphism of the large multifunctional peptidase 2 gene in the Spondyloarthritis Research Consortium of Canada Cohort. Arthritis Rheum. 2012 Apr; 64(4):1119–26. doi:10.1002/art.33430.; Lories R. The balance of tissue repair and remodeling in chronic arthritis. Nat Rev Rheumatol. 2011 Oct 18; 7(12):700–7. doi:10.1038/nrrheum.2011.156.

Διαθεσιμότητα: https://mrj.ima-press.net/mrj/article/view/602
https://doi.org/10.14412/1996-7012-2015-1-72-77

ЭФФЕКТИВНОСТЬ ГОЛИМУМАБА В ЛЕЧЕНИИ БОЛЬНЫХ АНКИЛОЗИРУЮЩИМ СПОНДИЛИТОМ (ПО ДАННЫМ ДЛИТЕЛЬНОГО НАБЛЮДЕНИЯ)

Συγγραφείς: Смирнов, Александр, Дубинина, Т., Эрдес, Ш.

Θεματικοί όροι: АНКИЛОЗИРУЮЩИЙ СПОНДИЛИТ, СТРУКТУРНЫЕ ИЗМЕНЕНИЯ, РЕНТГЕНОЛОГИЧЕСКОЕ ПРОГРЕССИРОВАНИЕ, ГОЛИМУМАБ

Περιγραφή αρχείου: text/html

Διαθεσιμότητα: http://cyberleninka.ru/article/n/effektivnost-golimumaba-v-lechenii-bolnyh-ankiloziruyuschim-spondilitom-po-dannym-dlitelnogo-nablyudeniya
http://cyberleninka.ru/article_covers/15713518.png

ВЗАИМОСВЯЗЬ УЛЬТРАЗВУКОВЫХ ПРИЗНАКОВ ВОСПАЛЕНИЯ СУСТАВОВ И РЕНТГЕНОЛОГИЧЕСКОГО ПРОГРЕССИРОВАНИЯ У ПАЦИЕНТОВ С РЕВМАТОИДНЫМ АРТРИТОМ

Πηγή: Научно-практическая ревматология.

Θεματικοί όροι: РЕВМАТОИДНЫЙ АРТРИТ,УЛЬТРАЗВУКОВОЕ ИССЛЕДОВАНИЕ СУСТАВОВ,РЕНТГЕНОЛОГИЧЕСКОЕ ПРОГРЕССИРОВАНИЕ,RHEUMATOID ARTHRITIS,JOINT ULTRASOUND STUDY,RADIOGRAPHIC PROGRESSION, 3. Good health

Περιγραφή αρχείου: text/html

Σύνδεσμος πρόσβασης: http://cyberleninka.ru/article_covers/17022539.png
http://cyberleninka.ru/article/n/vzaimosvyaz-ultrazvukovyh-priznakov-vospaleniya-sustavov-i-rentgenologicheskogo-progressirovaniya-u-patsientov-s-revmatoidnym

Evaluation of the structural changes of the hand joints and the rates of rheumatoid arthritis progression according to ultrasound data ; Оценка структурных изменений суставов кистей и темпов прогрессирования ревматоидного артрита по данным сонографии

Συγγραφείς: Rita Aleksandrovna Osipyants, D E Karateev, E Yu Panasyuk, G V Lukina, A V Smirnov, S I Glukhova, E N Aleksandrova, A V Volkov, E L Nasonov, Р. А. Осипянц, Дмитрий Евгеньевич Каратеев, Е. Ю. Панасюк, Г. В. Лукина, А. В. Смирнов, С. И. Глухова, Елена Николаевна Александрова, А. В. Волков, Евгений Львович Насонов

Πηγή: Rheumatology Science and Practice; Vol 51, No 2 (2013); 132-137 ; Научно-практическая ревматология; Vol 51, No 2 (2013); 132-137 ; 1995-4492 ; 1995-4484 ; 10.14412/1995-4484-2013-2

Θεματικοί όροι: рентгенологическое прогрессирование структурных изменений, hand joint ultrasonography, rheumatoid arthritis, X-ray progression of structural changes, ультрасонография суставов кисти, ревматоидный артрит

Περιγραφή αρχείου: application/pdf

Relation: https://rsp.mediar-press.net/rsp/article/view/777/470; Ревматология: Национальное руководство. Под ред. Е.Л. Насонова. M.: ГЭОTАР-Mедиа, 2010. Smolen J., Aletaha D., Bijsma J. et al. For the T2T Expert Committee. Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis 2010;69:613-7. Каратеев Д.Е. Современный взгляд на проблему быстропрогрессирующего ревматоидного артрита. Совр ревматол 2010;2:37-42. Smolen J.S., van der Heijde D.M., St Clair E.W. et al. Predictors ofjoint damage in patients with early rheumatoid arthritis treated with high-dose methotrexate with or without concomitant infliximab: results from the ASPIRE trial. Arthr Rheum 2006;54:702-10. Александрова Е.Н., Чемерис Н.А., Каратеев Д.Е. и др. Антитела к циклическому цитруллинированному пептиду при ревматоидном артрите. Tер арх 2004;12:64-8. Emery P., McInnes I., van Vollenhoven R., Kraan М. Clinical identification and treatment of a rapidly progressing disease state in patients with rheumatoid arthritis. Rheumatology (Oxford) 2008;47:392-8. Van der Heijde D.M., van Riel P.L., van Leeuwen M.A. et al. Prognostic factors for radiographic damage and physical disability in early rheumatoid arthritis. A prospective follow-up study of 147 patients. Br J Rheumatol 1992;31:519-25. Quinn M.A., Conaghan P., O'Connor P. et al. Very early treatment with infliximab in addition to methotrexate in early, poor-progno-sis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal. Arthr Rheum 2005;52:27-35. Brown A.K., Conaghan P.G., Karim Z. et al. An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis. Arthr Rheum 2008;58:2958-67. Aletaha D., Alasti F., Smolen J. Rheumatoid arthritis near remission: clinical rather than laboratory inflammation is associated with radiographic progression. Ann Rheum Dis 2011;70:1975-80. Wolfe F. Comparative usefulness of C-reactive protein and erythrocyte sedimentation rate in patients with rheumatoid arthritis. J Rheumatol 1997;24:1477-85. Klinkhoff A.V., Bellamy N., Bombardier C. et al. An experiment in reducing interobserver variability of the examination for joint tenderness. J Rheumatol 1988;15:492-4. Sharp J., Bluhm G., Brook A. et al. Reproducibility of multiple-observer scoring of radiologic abnormalities in the hands and wrists of patients with rheumatoid arthritis. Arthr Rheum 1985;28:16-24. Backhaus M., Kamradt T., Sandrock D. et al. Arthritis of the finger joints. A comprehensive Approach Comparing Conventional Radiography, Scintigraphy, Ultrasound, and Contrast-Enhanced Magnetic Resonance Imaging. Arthr Rheum 1999;42:1232-45. Devauchelle-Pensec V., Saraux A., Berthelot J. et al. Ability of hand radiographs to predict a further diagnosis of rheumatoid arthritis in patients with early arthritis. J Rheumatol 2001;28:2603-7. Wakefield R., Gibbon W., Conaghan P. et al. The value of sonography in the detection of bone erosions in patients with rheumatoid arthritis: a comparison with conventional radiography. Arthr Rheum 2000;43:2762-70. Szkudlarek M., Narvestad E., Klarlund M. et al. Ultrasonography of the metatarsophalangeal joints in rheumatoid arthritis. Comparison with magnetic resonance imaging, conventional radiography, and clinical examination. Arthr Rheum 2004;50:2103-12. Dоhn U., Ejbjerg B., Hasselquist M. et al. Detection of bone erosions in rheumatoid arthritis wrist joints with magnetic resonance imaging, computed tomography and radiography. Arthr Res Ther 2008;10:25. Hammer H., Haavardsholm E., Bоyesen P. et al. Bone erosions at the distal ulna detected by ultrasonography are associated with structural damage assessed by conventional radiography and MRI: a study of patients with recent onset rheumatoid arthritis. Rheumatology 2009;48:1530-2. Van der Heijde D. How to read radiographs according to the Sharp/van der Heijde method. J Rheumatol 2000;27:261-3. Smolen J., Aletaha D., Grisar J. et al. The need for prognosticators in rheumatoid arthritis. Biological and clinical markers: where are we now? Arthr Res Ther 2008;10:208. Сигидин Я.А., Лукина Г.В. Биологическая терапия в ревматологии. 2-е изд., доп.М.: Практическая медицина, 2009;302 с. Magnani M., Salizzoni E., Mule R. et al. Ultrasonography detection of early bone erosions in the metacarpophalangeal joints of patients with rheumatoid arthritis. Clin Exp Rheumatol 2004;22:743-8. Lopez-Ben R., Bernreuter W., Moreland L., Alarcon G. Ultrasound detection of bone erosions in rheumatoid arthritis: A comparison to routine radiographs of the hands and feet. Skeletal Radiol 2004;33:80-4. De Flaviis J., Scaglione P., Nessi R. et al. Ultrasonography of the hand in rheumatoid arthritis. Acta Radiol 1988;29:457-60. Bajaj S., Lopez-Ben R., Oster R., Alarcon G. Ultrasound detects rapid progression of erosive disease in early rheumatoid arthritis: A prospective longitudinal study. Skeletal Radiol 2007;36:123-8. Scheel A., Hermann K., Ohrndorf S. et al. Prospective 7-year follow-up imaging study comparing radiography, ultrasonography and magnetic resonance imaging in rheumatoid arthritis finger joints. Ann Rheum Dis 2006;66:595-600. Szkudlarek M., Klarlund M., Narvestad E. et al. Ultrasonography of the metacarpophalangeal and proximal interphalangeal joints in rheumatoid arthritis: A comparison with magnetic resonance imaging, conventional radiography and clinical examination. Arthr Res Ther 2006;52:8. Backhaus M., Ohrndorf S., Kellner H. et al. Evaluation of a novel 7-joint ultrasound score in daily rheumatologic practice: a pilot project. Arthr Rheum (Arthr Care Res) 2009;61:1194-201. Kawashiri S.-Y., Kawakami A., Iwamoto N. et al. The power Doppler ultrasonography score from 24 synovial sites or 6 simplified synovial sites, including the metacarpophalangeal joints, reflects the clinical disease activity and level of serum biomarkers in patients with rheumatoid arthritis. J Rheumatol 2010; doi:10.1093/rheumatology/keq415. Prevoo M., van't Hof M., Kuper H. et al. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthr Rheum 1995;38:44-8. Scire C., Montecucco C., Codullo V. et al. Ultrasonographic evaluation ofjoint involvement in early rheumatoid arthritis in clinical remission: power Doppler signal predicts short-term relapse. J Rheumatol 2009;48:1092-7. Hammer H., Kvien T. Comparisons of 7to 78-joint ultrasonography scores: All different joint combinations show equal response to adalimumab treatment in patients with rheumatoid arthritis. Arthr Res Ther 2011;13:78. Chary-Valckenaere I., Sommier J., Michel-Batot C. et al. Erosion and joint space narrowing in RA: proposition for a new semiquantitave score (ScuSST: Scoring by UltraSound Structural Total) [abstract]. Arthr Rheum 2006;54(Suppl):139. Funck-Brentano T., Etchepare F., Joulin S. et al. Benefits of ultrasonography in the management of early arthritis: a cross-sectional study of baseline data from the ESPOIR cohort. J Rheumatol 2009;48:1515-9. Иевлева Л.В., Сатыбалдыев А.М. Особенности ревматоидного артрита, начавшегося у лиц в возрасте 50 лет и старше. В кн.: Ревматоидный артрит. Под ред. члена-корр. АМН СССР проф. В.А.Насоновой (СССР) и проф. В. Лайне (Финляндия). М.: Медицина, 1983.

Διαθεσιμότητα: https://rsp.mediar-press.net/rsp/article/view/777
https://doi.org/10.14412/1995-4484-2013-639

EVALUATION OF ULTRASOUND REMISSION CRITERIA IN PATIENTS WITH RHEUMATOID ARTHRITIS DURING TOCILIZUMAB THERAPY ; Оценка ультразвуковых критериев ремиссии у пациентов с ревматоидным артритом на фоне терапии тоцилизумабом

Συγγραφείς: Rita Aleksandrovna Osipyants, D E Karateev, E Yu Panasyuk, G V Lukina, A V Smirnov, S I Glukhova, E N Aleksandrova, A V Volkov, E L Nasonov, Р. А. Осипянц, Дмитрий Евгеньевич Каратеев, Е. Ю. Панасюк, Г. В. Лукина, А. В. Смирнов, С. И. Глухова, Елена Николаевна Александрова, А. В. Волков, Евгений Львович Насонов

Πηγή: Rheumatology Science and Practice; Vol 51, No 5 (2013); 500-506 ; Научно-практическая ревматология; Vol 51, No 5 (2013); 500-506 ; 1995-4492 ; 1995-4484 ; 10.14412/1995-4484-2013-5

Θεματικοί όροι: тоцилизумаб, joint ultrasonography, subclinical synovitis, X-ray destruction progression, tocilizumab, ультразвуковое исследование суставов, субклинический синовит, рентгенологическое прогрессирование деструкции

Περιγραφή αρχείου: application/pdf

Relation: https://rsp.mediar-press.net/rsp/article/view/1335/995; Ревматология: Национальное руководство. Насонова ЕЛ, Насонова ВА. Москва: ГЭОТАР-Медиа; 2008. 296. [Revmatologiya: Natsional'noe rukovodstvo. Nasonova EL, Nasonova VA. Moscow: GEOTAR-Media; 2008. 296.] Pap T, Distler O. Linking angiogenesis to bone of destruction in arthritis. Arthritis Rheum. 2005;52(5):1346–8. DOI: http://dx.doi.org/10.1002%2Fart.21015. Puolakka K, Kautiainen H, Mottonen T et al. Impact of initial aggressive drug treatment with a combination of disease-modifying antirheumatic drugs on the development of the work disability in early rheumatoid arthritis: a five-year randomized followup trial. Arthritis Rheum. 2004;50(1):55–62. DOI: http://dx.doi.org/10.1002%2Fart.11436. Каратеев ДЕ, Лучихина ЕЛ. Современные принципы лечения ревматоидного артрита: акцент на раннюю агрессивную терапию. Эффективная фармакотерапия. 2011;1:12–7. [Karateev DE, Luchikhina EL. Sovremennye printsipy lecheniya revmatoidnogo artrita: aktsent na rannyuyu agressivnuyu terapiyu. Effektivnaya farmakoterapiya. 2011;1:12–7.] Smolen J, Landewe R, Breedveld F et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis. 2010;69(6):964–75. DOI:10.1136/ard.2009.126532. Epub 2010 May 5. Brown AK, Quinn MA, Karim Z et al. Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug-induced clinical remission: evidence from an imaging study may explain structural progression. Arthritis Rheum. 2006;54(12):3761–73. DOI:10.1002%2Fart.22190. Balsa A, de Miguel E, Castillo C et al. Superiority of SDAI over DAS-28 in assessment of remission in rheumatoid arthritis patients using power Doppler ultrasonography as a gold standard. Rheumatology (Oxford). 2010;49(4):683-90. DOI:10.1093/rheumatology/kep442. Epub 2010 Jan 4. Ma M, Scott I, Kingsley H et al. Remission in Early Rheumatoid Arthritis. J Rheumatol 2010;37(7):1444–53. Taylor P, Steuer A, Gruber J et al. Comparison of ultrasonographic assessment of synovitis and joint vascularity with radiographic evaluation in a randomized, placebo-controlled study of Infliximab therapy in early rheumatoid arthritis. Arthritis Rheum. 2004;50(4):1107–16. DOI: http://dx.doi.org/10.1002%2Fart.20123. Jimenez-Boj E, Nobauer-Huhmann I, Hanslik-Schnabel B et al. Bone erosions and bone marrow edema as defined by magnetic resonance imaging reflect true bone marrow inflammation in rheumatoid arthritis. Arthritis Rheum. 2007;56(4):1118–24. DOI: http://dx.doi.org/10.1002%2Fart.22496. Fukae J, Isobe M, Kitano A et al. Radiographic prognosis of finger joint damage predicted by early alteration in synovial vascularity in patients with rheumatoid arthritis: potential utility of power Doppler sonography in clinical practice. Arthritis Care Res (Hoboken) 2011;63(9):1247–53. DOI: http://dx.doi.org/10.1002%2Facr.20517 Brown AK, Conaghan PG, Karim Z et al. An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis. Arthritis Rheum 2008;58(10):2958–67. DOI:10.1002/art.23945. Foltz V, Gandjbakhch F, Etchepare F et al. Power Doppler but not low-field MRI predict relapse and radiographic disease progression in rheumatoid arthritis patients with low disease activity. Arthritis Rheum. 2012;64(1):67–76. DOI:10.1002/art.33312. Prevoo MLL, van Hoff MA, Kuper HH et al. Modified disease activity scores that include twenty-eight-joints counts. Arthritis Rheum. 1995;38(1):44–52. DOI: http://dx.doi.org/10.1002%2Fart.1780380107. Smolen J, Breedveld F, Schiff M et al. A simplified disease activity index for rheumatoid arthritis for use in clinical practice. Rheumatology (Oxford). 2003;42:244–57. DOI: http://dx.doi.org/10.1093%2Frheumatology%2Fkeg072. Kosinski M, Zhao SZ, Dedhiya S et al. Determing minimally important changes in general and disease-specific health-related quality of life questionnaires in clinical trials of rheumatoid arthritis. Arhtritis Rheum. 2000;43(7):1478–87. Van der Heijde D. How to read radiographs according to the Sharp/van der Heijde method. J Rheumatol. 2000;27(1):261–3. Wakefield RJ, Balint PV, Szkudlarek M et al. Musculoskeletal ultrasound including definitions for ultrasonographic pathology. J Rheumatol. 2005;32(12):2485–7. Peluso G, Michelutti A, Bosello S et al. Clinical and ultrasonographic remission determines different chances of relapse in early and long standing rheumatoid arthritis. Ann Rheum Dis. 2011;70(1):172–5. DOI:10.1136/ard.2010.129924. Epub 2010 Nov 19. Aletaha D, Ward M, Machold K et al. Remission and active disease in rheumatoid arthritis: defining criteria for disease activity states. Arthritis Rheum. 2005;52(9):2625–36. Wakefield R, D’Agostino MA, Naredo E et al. After treat-to target: can a targeted ultrasound initiative improve RA outcomes? Ann Rheum Dis. 2012;71(6):799–803. DOI:10.1136/annrheumdis-2011-201048. Epub 2012 May 5. Jacobsson L, Hetland M. New remission criteria for RA: «modern times» in rheumatology not a silent film, rather a 3D movie. Ann Rheum Dis. 2011;70(3):401–3. DOI:10.1136/ard.2010.145607. Saleem B, Brown A, Keen H et al. Should imaging be a component of rheumatoid arthritis remission criteria? A comparison between traditional and modified composite remission scores and imaging assessments. Ann Rheum Dis. 2011;70(5):792–8. DOI:10.1136/ard.2010.134445. Epub 2011 Jan 17. Townes S, Furst D, Thenkondar A et al. The impact of tocilizumab on physical function and quality of life in patients with rheumatoid arthritis: a systemic literature review and interpretation. Open Access Rheumatology: Research and Reviews. 2012;4:87–92. Smolen J, Aletaha D, Bijsma J et al. For the T2T Expert Committee. Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis. 2010;69(4):613–7. DOI:10.1136/ard.2009.123919. Epub 2010 Mar 9. Saleem B, Brown A, Keen H et al. Disease remission state in patients treated with the combination of tumor necrosis factor blockade and methotrexate or with disease-modifying antirheumatic drugs. Arthritis Rheum. 2009;60(7):1915–22. DOI:10.1002/art.24596. Scire C, Montecucco C., Codullo V et al. Ultrasonographic evaluation of joint involvement in early rheumatoid arthritis in clinical remission: power Doppler signal predicts short-term relapse. Rheumatology (Oxford). 2009;48(9):1092–7. DOI:10.1093/rheumatology/kep171. Epub 2009 Jun 26. Smolen JS, Han C, van der Heijde DM et al .Active-Controlled Study of Patients Receiving Infliximab for the Treatment of Rheumatoid Arthritis of Early Onset (ASPIRE) Study Group. Radiographic changes in rheumatoid arthritis patients attaining different disease activity states with methotrexate monotherapy and infliximab plus methotrexate: the impacts of remission and tumour necrosis factor blockade. Ann Rheum Dis. 2009;68:823–7. Aletaha D, Alasti F, Smolen JS. Rituximab dissociates the tight link between diseases activity and joint damage in rheumatoid arthritis patients. Ann Rheum Dis. 2012;72(1):7–12. DOI:10.1136/annrheumdis-2012-201970. Epub 2012 Aug 21. Emery P, Genovese M, van Vollenhoven R et al. Less radiographic progression with adalimumab plus methotrexate monotherapy across the spectrum of clinical response in early rheumatoid arthritis. J Rheumatol. 2009;36(7):1421–41. DOI:10.3899/jrheum.081018. Epub 2009 Apr 15. Cohen S, Dore R, Lane N et al.; Denosumab Rheumatoid Arthritis Study Group. Denosumab treatment effects on structural damage, bone density, and bone turnover in rheumatoid arthritis: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial. Arthritis Rheum. 2008;58(5):1299–309. DOI:10.1002/art.23417. Smolen J, Avila J, Aletaha D. Tocilizumab inhibits progression of joint damage in rheumatoid arthritis irrespective of its anti-inflammatory effects: disassociation of the link between inflammation and destruction. Ann Rheum Dis. 2012;71(5):687–93. DOI:10.1136/annrheumdis-2011-200395. Epub 2011 Nov 25.

Διαθεσιμότητα: https://rsp.mediar-press.net/rsp/article/view/1335
https://doi.org/10.14412/1995-4484-2013-1540

Pain as one of the risk factors for progression of knee osteoarthrosis ; Боль как один из факторов риска прогрессирования остеоартроза коленных суставов

Συγγραφείς: Natalia Gavriilovna Kashevarova, E M Zaitseva, A V Smirnov, L I Alekseeva, Н. Г. Кашеварова, Е. М. Зайцева, А. В. Смирнов, Людмила Ивановна Алексеева

Πηγή: Rheumatology Science and Practice; Vol 51, No 4 (2013); 387-390 ; Научно-практическая ревматология; Vol 51, No 4 (2013); 387-390 ; 1995-4492 ; 1995-4484 ; 10.14412/1995-4484-2013-4

Θεματικοί όροι: рентгенологическое прогрессирование, intensive pain, radiographic progression, интенсивная боль

Περιγραφή αρχείου: application/pdf

Relation: https://rsp.mediar-press.net/rsp/article/view/1150/822; Hart D.J., Spector T.D., Brown P. et al. Clinical signs of early osteoarthritis: reproducibility and relation to x ray changes in 541 women in the general population. Ann Rheum Dis 1991;50:467-70. Felson D.T. The epidemiology of knee osteoarthritis: results from the Framingham Osteoarthritis Study. Semin Arthr Rheum 1990;20:42-50. Claessens A.A., Schouten J.S.A.G., van den Ouweland F.A., Valkenburg H.A. Do clinical findings associate with radiographic osteoarthritis of the knee? Ann Rheum Dis 1990;49:771-4. Bedson J., Croft P.R. The discordance between clinical and radiographic knee osteoarthritis: A systematic search and summary of the literature. BMC Musculoskeletal Disorders 2008;9:116. Lanyon P., O'Reilly S., Jones A., Doherty M. Radiographic assessment of symptomatic knee osteoarthritis in the community: definitions and normal joint space. Ann Rheum Dis 1998;57:595-601. McAlindon T.E., Snow S., Cooper C., Dieppe P.A. Radiographic patterns of osteoarthritis of the knee joint in the community: The importance of the patellofemoral joint. Ann Rheum Dis 1992;51:844-9. Lachance L., Sowers M., Jamadar D. et al. The experience of pain and emergent osteoarthritis of the knee. Osteoarth Cartilage 2001;9:527-32. Petersson I.F., Boegard T., Saxne T. et al. Radiographic osteoarthritis of the knee classified by the Ahlback and Kellgren and Lawrence systems for the tibiofemoral joint in people aged 35-54 years with chronic knee pain. Ann Rheum Dis 1997;56:493-6. Ang D.C., Ibrahim S.A., Burant C.J., Kwoh C.K. Is there a difference in the perception of symptoms between African Americans and Whites with osteoarthritis? J Rheumatol 2003;30:1305-10. Cicuttini F.M., Baker J., Hart D.J., Spector T.D. Association of pain with radiological changes in different compartments and views of the knee joint. Osteoarthr Cartilage 1996;4:143-7. Davis M.A., Ettinger W.H., Neuhaus J.M. et al. Correlates of knee pain among US adults with and without radiographic knee osteoarthritis. J Rheumatol 1992;19:1943-9. Odding E., Valkenburg H.A., Algra D. et al. Associations of radiological osteoarthritis of the hip and knee with locomotor disability in the Rotterdam study. Ann Rheum Dis 1998;57:203-8. Wolfe F., Lane N.E. The longterm outcome of osteoarthritis: rates and predictors ofjoint space narrowing in symptomatic patients with knee osteoarthritis. J Rheumatol 2002;29:139-46. Dieppe P., Cushnaghan J., Young P., Kirwan J. Prediction of the progression of joint space narrowing in osteoarthritis of the knee by bone scintigraphy. Ann Rheum Dis 1993;52:557-63. Cooper C., Snow S., McAlindon T.E. et al. Risk factors for the incidence and progression of radiographic knee osteoarthritis. Arthr Rheum 2000;43:995-1000. Amin S., Guermazi A., Lavalley M.P. et al. Complete anterior cruciate ligament tear and the risk for cartilage loss and progression of symptoms in men and women with knee osteoarthritis. Osteoarthr Cartilage 2008;16:897-902. Altman R., Asch E., Bloch D. et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Arthr Rheum 1986;29:1039-49. Conaghan P.G., DAgostino M.A., Le Bars M. et al. Clinical and ultrasonographic predictors ofjoint replacement for knee osteoarthritis: results from a large, 3-year, prospective EULAR study. Ann Rheum Dis 2010;69:644-7. Rogers M.W., Wilder F.V. The association of BMI and knee pain among persons with radiographic knee osteoarthritis: A cross-sectional study. BMC Musculoskelet Disord 2008;9:163. Neogi T., Nevitt M., Niu J. et al. Subchondral bone attrition may be a reflection of compartment-specific mechanical load: the MOST Study. Ann Rheum Dis 2010;69:841-4. Sowers M.F., Hayes C., Jamadar D. et al. Magnetic resonance-detected subchondral bone marrow and cartilage defect characteristics associated with pain and X-ray-defined knee osteoarthritis. Osteoarthr Cartilage 2003;11:387-93.

Διαθεσιμότητα: https://rsp.mediar-press.net/rsp/article/view/1150
https://doi.org/10.14412/1995-4484-2013-1249

Факторы прогрессирования остеоартроза коленных суставов (5-летнее проспективноенаблюдение)

Συγγραφείς: Кашеварова, Н., Зайцева, Е., Пушкова, О., Смирнов, А., Алексеева, Л.

Θεματικοί όροι: ОСТЕОАРТРОЗ КОЛЕННЫХ СУСТАВОВ, ИНТЕНСИВНАЯ БОЛЬ, СИНОВИТ, РЕНТГЕНОЛОГИЧЕСКОЕ ПРОГРЕССИРОВАНИЕ

Περιγραφή αρχείου: text/html

Διαθεσιμότητα: http://cyberleninka.ru/article/n/faktory-progressirovaniya-osteoartroza-kolennyh-sustavov-5-letnee-prospektivnoenablyudenie
http://cyberleninka.ru/article_covers/14506060.png

БОЛЬ КАК ОДИН ИЗ ФАКТОРОВ РИСКА ПРОГРЕССИРОВАНИЯ ОСТЕОАРТРОЗА КОЛЕННЫХ СУСТАВОВ

Συγγραφείς: Кашеварова, Наталья, Зайцева, Е., Смирнов, А., Алексеева, Л.

Θεματικοί όροι: ОСТЕОАРТРОЗ КОЛЕННЫХ СУСТАВОВ, ИНТЕНСИВНАЯ БОЛЬ, РЕНТГЕНОЛОГИЧЕСКОЕ ПРОГРЕССИРОВАНИЕ

Περιγραφή αρχείου: text/html

Διαθεσιμότητα: http://cyberleninka.ru/article/n/bol-kak-odin-iz-faktorov-riska-progressirovaniya-osteoartroza-kolennyh-sustavov
http://cyberleninka.ru/article_covers/14468606.png

ОЦЕНКА СТРУКТУРНЫХ ИЗМЕНЕНИЙ СУСТАВОВ КИСТЕЙ И ТЕМПОВ ПРОГРЕССИРОВАНИЯ РЕВМАТОИДНОГО АРТРИТА ПО ДАННЫМ СОНОГРАФИИ

Συγγραφείς: Осипянц, Рита, Каратеев, Д., Панасюк, Е., Лукина, Г., Смирнов, А., Глухова, С., Александрова, Е., Волков, А., Насонов, Е.

Θεματικοί όροι: СОНОГРАФИЧЕСКИЙ ИНДЕКС ДЕСТРУКЦИИ, УЛЬТРАСОНОГРАФИЯ СУСТАВОВ КИСТИ, РЕВМАТОИДНЫЙ АРТРИТ, РЕНТГЕНОЛОГИЧЕСКОЕ ПРОГРЕССИРОВАНИЕ СТРУКТУРНЫХ ИЗМЕНЕНИЙ

Περιγραφή αρχείου: text/html

Διαθεσιμότητα: http://cyberleninka.ru/article/n/otsenka-strukturnyh-izmeneniy-sustavov-kistey-i-tempov-progressirovaniya-revmatoidnogo-artrita-po-dannym-sonografii
http://cyberleninka.ru/article_covers/14419658.png

ОЦЕНКА УЛЬТРАЗВУКОВЫХ КРИТЕРИЕВ РЕМИССИИ У ПАЦИЕНТОВ С РЕВМАТОИДНЫМ АРТРИТОМ НА ФОНЕ ТЕРАПИИ ТОЦИЛИЗУМАБОМ

Συγγραφείς: Осипянц, Рита, Каратеев, Д., Панасюк, Е., Лукина, Г., Смирнов, А., Глухова, С., Александрова, Е., Волков, А., Насонов, Е.

Θεματικοί όροι: РЕМИССИЯ РЕВМАТОИДНОГО АРТРИТА, УЛЬТРАЗВУКОВОЕ ИССЛЕДОВАНИЕ СУСТАВОВ, СУБКЛИНИЧЕСКИЙ СИНОВИТ, РЕНТГЕНОЛОГИЧЕСКОЕ ПРОГРЕССИРОВАНИЕ ДЕСТРУКЦИИ, ТОЦИЛИЗУМАБ

Περιγραφή αρχείου: text/html

Διαθεσιμότητα: http://cyberleninka.ru/article/n/otsenka-ultrazvukovyh-kriteriev-remissii-u-patsientov-s-revmatoidnym-artritom-na-fone-terapii-totsilizumabom
http://cyberleninka.ru/article_covers/15528946.png

IMPACT OF TOCILIZUMAB THERAPY ON STRUCTURAL JOINT DAMAGE PROGRESSION IN RHEUMATOID ARTHRITIS ; ВЛИЯНИЕ ТЕРАПИИ ТОЦИЛИЗУМАБОМ НА ПРОГРЕССИРОВАНИЕ ДЕСТРУКЦИИ СУСТАВОВ У БОЛЬНЫХ РЕВМАТОИДНЫМ АРТРИТОМ

Συγγραφείς: Anastasia Sergeevna Avdeeva, A V Smirnov, E Yu Panasyuk, E N Alexandrova, E L Nasonov, А. В. Смирнов, Е. Ю. Панасюк, Евгений Львович Насонов

Πηγή: Rheumatology Science and Practice; Vol 50, No 5 (2012); 25-29 ; Научно-практическая ревматология; Vol 50, No 5 (2012); 25-29 ; 1995-4492 ; 1995-4484 ; 10.14412/1995-4484-2012-5

Θεματικοί όροι: рентгенологическое прогрессирование, CDAI, rheumatoid arthritis, tocilizumab, SDAI, radiographic progression, тоцилизумаб

Περιγραφή αρχείου: application/pdf

Relation: https://rsp.mediar-press.net/rsp/article/view/1090/763; Насонов Е.Л., Каратеев Д.Е., Балабанова Р.М. Ревматоидный артрит. В кн.: Ревматология. Национальное руководство. Под ред. Е.Л. Насонова, В.А. Насоновой. М.: ГЭОТАР-Медиа, 2008; 290—331. Новиков А.А., Александрова Е.Н., Диатроптова М.А., Насонов Е.Л. Роль цитокинов в патогенезе ревматоидного артрита. Науч.-практич. ревматол. 2010; 2: 71—82. Jones G., Darian-Smith E., Kwok M. et al. Effect of biologic therapy on radiological progression in rheumatoid arthritis: what does it add to methotrexate? Biologics 2012; 6: 155—61. Smolen J.S., Aletaha D., Bijsma J.W.J. et al. For the T2T Exspert Committee. Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis 2010; 69: 6317. Nishimoto N., Kishimoto T. Humanized antihuman IL-6 receptor antibody, tocilizumab. Handb Exp Pharmacol 2008; (181): 151—60. Насонов Е.Л. Новые подходы к фармакотерапии ревматоидного артрита: перспективы применения тоцилизумаба (моноклональные антитела к рецептору интерлейкина-6). Тер. арх. 2010; 5: 64—71. Dayer J.M., Choy E. Therapeutic targets in rheumatoid arthritis: the interleukin-6 receptor. Rheumatology (Oxford) 2010; 49: 15—24. Fonseca J.E., Santos M.J., Canhao H. et al. Interleukin-6 as a key player in systemic inflammation and joint destruction. Autoimmun Rev 2009; 8: 538—42. Kudo O., Sabokbar A., Pocock A. et al. Interleukin-6 and interleukin-11 support human osteoclast formation by a RANKL-independent mechanism. Bone 2003; 32: 1-7. Paleolog E.M. Angiogenesis in rheumatoid arthritis. Arthr Res 2002; 4(Suppl. 3): 81—90. Smolen J.S., Aletaha D., Koeller M. et al. New therapies for treatment of rheumatoid arthritis. Lancet 2007; 370: 1861-74. Kotake S., Sato K., Kim K.J. et al. Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation. J Bone Miner Res 1996; 11: 88-95. Sack U., Kinne R.W., Marx T. et al. Interleukin-6 in synovial fluid is closely associated with chronic synovitis in rheumatoid arthritis. Rheumatol Int 1993; 13: 45-51. Aletaha D., Nell V., Stamm T. et al. Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score. Arthr Res Ther 2005: 7; R796—R806. Welsing P., Landewe R, van Riel P. et al. The relationship between disease activity and radiologic progression in patients with rheumatoid arthritis: a longitudinal analysis. Arthr Rheum 2004; 50: 2082—93. Frey N., Grange S., Woodworth T. Relationship between serum concentration of the interleukin-6 receptor inhibitor tocilizumab and C-reactive protein reduction in RA patients: 6 months data from a phase 3 study. Arthr Rheum 2007; 56(Suppl. 9): 148—9. Choy E.H., Isenberg D.A., Garrood T. et al. Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalation trial. Arthr Rheum 2002; 46: 3143-50. Nishimoto N., Terao K., Mima T. et al. Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease. Blood 2008; 112: 3959-64. Насонов Е.Л., Панасюк Е.Ю., Булдаков С.Г. и др. Эффективность и безопасность тоцилизумаба при ревматоидном артрите (промежуточные результаты российского многоцентрового исследования). Науч.-практич. ревматол. 2009; 2: 21-9. Александрова Е.Н., Панасюк Е.Ю., Авдеева А.С. и др. Динамика лаб. ораторных биомаркеров у больных ревматоидным артритом на фоне терапии тоцилизумабом. Науч.-практич. ревматол. 2011; 3: 14-9. Панасюк Е.Ю., Амирджанова В.Н., Александрова Е.Н. и др. Быстрый эффект тоцилизумаба при ревматоидном артрите. Науч.-практич. ревматол. 2011; 4: 11-6. Garnero P., Thompson E., Woodworth T. Rapid and sustained improvement in bone and cartilage turnover markers with the antiinterleukin-6 receptor inhibitor tocilizumab plus methotrexate in rheumatoid arthritis patients with an inadequate response to methotrexate. Arthr Rheum 2010; 62: 33-43. Yokoe I., Nishio S., Sato H. et al. Comparison of MMP-3 levels in rheumatoid arthritis after treatment with tocilizumab or infliximab for 12 weeks. Mod Rheumatol 2011: 21: 710—4 Tanaka Y., Takeuchi T., Amano K. et al. Impact of tocilizumab therapy for remission quartet in rheumatoid arthritis-the result of 104 weeks follow up data of REACTION study. Arthr Rheum 2011; 63(Suppl.): S483. Tanaka Y., Takeuchi T., Amano K. et al. Impact of tocilizumab therapy after switching from tumor necrosis factor (TNF) inhibitors — prevention of joint damage by tocilizumab in patients with inadequate response to anti-TNF therapies. Arthr Rheum 2011; 63(Suppl.): S484. Nishimoto N., Hashimoto J., Miyasaka N. et al. Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): evidence of clinical and radiographic beneët from an X ray reader-blinded randomised controlled trial of tocilizumab. Ann Rheum Dis 2007; 66: 1162—7. Kremer J., Blanco R., Brzosko M. et al. Tocilizumab inhibits structural joint damage in rheumatoid arthritis patients with inadequate responses to methotrexate: Results from the double-blind treatment phase of a randomized placebo-controlled trial of tocilizumab safety and prevention of structural joint damage at one year. Arthr Rheum 2011; 63: 609-21. Fleischmann R., Burgos-Vargas R., Skopouli F.N. et al. Tocilizumab inhibits radiographic progression, improves physical function, and gains efficacy over time: LITHE 2 year. Ann Rheum Dis 2010; 69(Suppl. 3): 384. Fransen J., Stucki G., van Reil P.L.C.M. Rheumatoid arthritis measures. Arthr Rheum 2003; 49: 214-24. Smolen J., Breedveld F., Schiff M. et al. A simplified disease activity index for rheumatoid arthritis for use in clinical practice. Rheumatology 2003; 42: 244-57. Shaver T.S., Anderson J.D., Weidensaul D.N. et al. The problem of rheumatoid arthritis disease activity and remission in clinical practice. J Rheumatol 2008; 35: 1015-22. Van der Heijde D. How to read radiographs according to the Sharp/van der Heijde method. J Rheumatol 1999; 26: 743-5. Смирнов А.В. Атлас рентгенологической диагностики ревматоидного артрита. М.: ИМА-ПРЕСС, 2009. Takeuchi T., Tanaka Y., Amano K. et al. Clinical, radiographic and functional effectiveness of tocilizumab for rheumatoid arthritis patients — REACTION 52-week study. Rheumatology 2011; 50: 1908-15. Svensson B., Boonen A., Albertsson K. et al. Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate. Arthr Rheum 2005; 52: 3360-70. Wassenberg S., Rau R., Steinfeld P. et al. Very low-dose prednisolone in early rheumatoid arthritis retards radiographic progression over two years a multicenter, double-blind, placebo-controlled trial. Arthr Rheum 2005; 52: 3371-80. Hafström I., Albertsson K., Boonen A. et al. Remission achieved after 2 years treatment with low-dose prednisolone in addition to diseasemodifying anti-rheumatic drugs in early rheumatoid arthritis is associated with reduced joint destruction still present after 4 years: an open 2-year continuation study. Ann Rheum Dis 2009; 68: 508-13. Plant M.J., Williams A.L., O'Sullivan M.M. et al. Relationship between time-integrated C-reactive protein levels and radiologic progression in patients with rheumatoid arthritis. Arthr Rheum 2000; 43: 1473-7. Van Leeuwen M.A., van Rijswijk M.H., van der Heijde D.M. et al. The acute-phase response in relation to radiographic progression in early rheumatoid arthritis: a prospective study during the first three years of the disease. Br J Rheumatol 1993; 32: 9-13. Van der Heide A., Remme C.A., Hofman D.M. et al. Prediction of progression of radiologic damage in newly diagnosed rheumatoid arthritis. Arthr Rheum 1995; 38: 1466-74. Smolen J., Avila J., Aletaha D. et al. Tocilizumab (TCZ) inhibits progression of joint damage in rheumatoid arthritis (RA) irrespective of its antiinflammatory effects: disassociation of the link between inflammation and destruction. Arthr Rheum 2011; 63(Suppl.): S630. Dougados M., Kissel K., Amital H. et al. Double-blind study of tocilizumab plus methotrexate vs tocilizumab plus placebo in patients with active rheumatoid arthritis despite prior methotrexate: progression of structural damage, quality of life, and physical function at 24 weeks. Arthr Rheum 2011; 63(Suppl.): S1032.

Διαθεσιμότητα: https://rsp.mediar-press.net/rsp/article/view/1090
https://doi.org/10.14412/1995-4484-2012-1176